date
Note that the current default version of R is 3.6.1.
Loading required package: network
network: Classes for Relational Data
Version 1.15 created on 2019-04-01.
copyright (c) 2005, Carter T. Butts, University of California-Irvine
                    Mark S. Handcock, University of California -- Los Angeles
                    David R. Hunter, Penn State University
                    Martina Morris, University of Washington
                    Skye Bender-deMoll, University of Washington
 For citation information, type citation("network").
 Type help("network-package") to get started.


networkDynamic: version 0.10.0, created on 2019-04-04
Copyright (c) 2019, Carter T. Butts, University of California -- Irvine
                    Ayn Leslie-Cook, University of Washington
                    Pavel N. Krivitsky, University of Wollongong
                    Skye Bender-deMoll, University of Washington
                    with contributions from
                    Zack Almquist, University of California -- Irvine
                    David R. Hunter, Penn State University
                    Li Wang
                    Kirk Li, University of Washington
                    Steven M. Goodreau, University of Washington
                    Jeffrey Horner
                    Martina Morris, University of Washington
Based on "statnet" project software (statnet.org).
For license and citation information see statnet.org/attribution
or type citation("networkDynamic").

Loading required package: statnet.common

Attaching package: ‘statnet.common’

The following object is masked from ‘package:base’:

    order

sna: Tools for Social Network Analysis
Version 2.4 created on 2016-07-23.
copyright (c) 2005, Carter T. Butts, University of California-Irvine
 For citation information, type citation("sna").
 Type help(package="sna") to get started.


ergm: version 3.10.4, created on 2019-06-10
Copyright (c) 2019, Mark S. Handcock, University of California -- Los Angeles
                    David R. Hunter, Penn State University
                    Carter T. Butts, University of California -- Irvine
                    Steven M. Goodreau, University of Washington
                    Pavel N. Krivitsky, University of Wollongong
                    Martina Morris, University of Washington
                    with contributions from
                    Li Wang
                    Kirk Li, University of Washington
                    Skye Bender-deMoll, University of Washington
                    Chad Klumb
Based on "statnet" project software (statnet.org).
For license and citation information see statnet.org/attribution
or type citation("ergm").

NOTE: Versions before 3.6.1 had a bug in the implementation of the bd()
constriant which distorted the sampled distribution somewhat. In
addition, Sampson's Monks datasets had mislabeled vertices. See the
NEWS and the documentation for more details.

NOTE: Some common term arguments pertaining to vertex attribute and
level selection have changed in 3.10.0. See terms help for more
details. Use ‘options(ergm.term=list(version="3.9.4"))’ to use old
behavior.


tergm: version 3.6.1, created on 2019-06-12
Copyright (c) 2019, Pavel N. Krivitsky, University of Wollongong
                    Mark S. Handcock, University of California -- Los Angeles
                    with contributions from
                    David R. Hunter, Penn State University
                    Steven M. Goodreau, University of Washington
                    Martina Morris, University of Washington
                    Nicole Bohme Carnegie, New York University
                    Carter T. Butts, University of California -- Irvine
                    Ayn Leslie-Cook, University of Washington
                    Skye Bender-deMoll
                    Li Wang
                    Kirk Li, University of Washington
Based on "statnet" project software (statnet.org).
For license and citation information see statnet.org/attribution
or type citation("tergm").

Starting maximum pseudolikelihood estimation (MPLE):
Evaluating the predictor and response matrix.
Maximizing the pseudolikelihood.
Finished MPLE.
Starting Monte Carlo maximum likelihood estimation (MCMLE):
Iteration 1 of at most 500:
Optimizing with step length 0.662366729604356.
The log-likelihood improved by 2.679.
Iteration 2 of at most 500:
Optimizing with step length 1.
The log-likelihood improved by 0.8268.
Step length converged once. Increasing MCMC sample size.
Iteration 3 of at most 500:
Optimizing with step length 1.
The log-likelihood improved by 0.03411.
Step length converged twice. Stopping.
Finished MCMLE.
This model was fit using MCMC.  To examine model diagnostics and check
for degeneracy, use the mcmc.diagnostics() function.
 degree0  degree1  degree2  degree3  degree4  degree5  degree6  degree7 
       1       21     1226     1012      811      345      380      361 
 degree8  degree9 degree10 degree11 degree12 degree13 degree14 degree15 
     282      223      140       92       59       25       12        4 
degree16 degree17 
       3        3 
1 
disease_progression 
H-positive risk:  850 940 133 882 444 117 823 455 111 58 138 49 
H-negative risk:  940 850 823 882 455 444 117 133 138 111 49 58 
New BC onsets:  1
BC status:  4999 1 
BC subtype:  4999 1 

clinical_engagement 
diagnosis 
demography 
65 new agents 
2 
disease_progression 
H-positive risk:  850 950 132 876 437 119 827 452 109 59 138 51 
H-negative risk:  950 850 827 876 452 437 119 132 138 109 51 59 
New BC onsets:  3
BC status:  4997 3 
BC subtype:  4997 2 1 

clinical_engagement 
diagnosis 
demography 
64 new agents 
3 
disease_progression 
H-positive risk:  858 956 131 872 435 118 825 446 110 60 140 49 
H-negative risk:  956 858 825 872 446 435 118 131 140 110 49 60 
New BC onsets:  5
BC status:  4995 5 
BC subtype:  4995 4 1 

clinical_engagement 
diagnosis 
demography 
54 new agents 
4 
disease_progression 
H-positive risk:  861 958 131 878 434 116 821 440 112 59 142 48 
H-negative risk:  958 861 821 878 440 434 116 131 142 112 48 59 
New BC onsets:  7
BC status:  4993 7 
BC subtype:  4993 6 1 

clinical_engagement 
diagnosis 
demography 
69 new agents 
5 
disease_progression 
H-positive risk:  864 964 131 884 425 117 817 440 112 56 142 48 
H-negative risk:  964 864 817 884 440 425 117 131 142 112 48 56 
New BC onsets:  9
BC status:  4991 9 
BC subtype:  4991 7 2 

clinical_engagement 
diagnosis 
demography 
52 new agents 
6 
disease_progression 
H-positive risk:  870 966 132 881 420 118 815 437 113 57 141 50 
H-negative risk:  966 870 815 881 437 420 118 132 141 113 50 57 
New BC onsets:  9
BC status:  4991 9 
BC subtype:  4991 7 2 

clinical_engagement 
diagnosis 
demography 
55 new agents 
7 
disease_progression 
H-positive risk:  878 973 136 876 416 119 807 432 114 57 143 49 
H-negative risk:  973 878 807 876 432 416 119 136 143 114 49 57 
New BC onsets:  12
BC status:  4988 12 
BC subtype:  4988 9 3 

clinical_engagement 
diagnosis 
demography 
61 new agents 
8 
disease_progression 
H-positive risk:  882 979 136 864 413 121 818 431 111 55 143 47 
H-negative risk:  979 882 818 864 431 413 121 136 143 111 47 55 
New BC onsets:  12
BC status:  4988 12 
BC subtype:  4988 9 3 

clinical_engagement 
diagnosis 
demography 
75 new agents 
9 
disease_progression 
H-positive risk:  881 982 133 866 413 122 823 427 112 56 140 45 
H-negative risk:  982 881 823 866 427 413 122 133 140 112 45 56 
New BC onsets:  13
BC status:  4987 13 
BC subtype:  4987 9 4 

clinical_engagement 
diagnosis 
demography 
65 new agents 
10 
disease_progression 
H-positive risk:  883 990 132 866 409 125 821 424 111 56 141 42 
H-negative risk:  990 883 821 866 424 409 125 132 141 111 42 56 
New BC onsets:  15
BC status:  4985 15 
BC subtype:  4985 11 4 

clinical_engagement 
diagnosis 
demography 
66 new agents 
11 
disease_progression 
H-positive risk:  885 987 134 871 402 129 820 426 106 57 141 42 
H-negative risk:  987 885 820 871 426 402 129 134 141 106 42 57 
New BC onsets:  16
BC status:  4984 16 
BC subtype:  4984 11 5 

clinical_engagement 
diagnosis 
demography 
58 new agents 
12 
disease_progression 
H-positive risk:  890 994 136 864 397 130 822 423 107 57 140 40 
H-negative risk:  994 890 822 864 423 397 130 136 140 107 40 57 
New BC onsets:  17
BC status:  4983 17 
BC subtype:  4983 11 6 

clinical_engagement 
diagnosis 
demography 
58 new agents 
13 
disease_progression 
H-positive risk:  812 890 130 970 387 114 909 423 122 53 150 40 
H-negative risk:  890 812 909 970 423 387 114 130 150 122 40 53 
New BC onsets:  20
BC status:  4980 20 
BC subtype:  4980 13 7 

clinical_engagement 
diagnosis 
demography 
216 new agents 
14 
disease_progression 
H-positive risk:  837 929 138 913 401 115 871 441 112 53 146 44 
H-negative risk:  929 837 871 913 441 401 115 138 146 112 44 53 
New BC onsets:  23
BC status:  4977 23 
BC subtype:  4977 16 7 

clinical_engagement 
diagnosis 
demography 
55 new agents 
15 
disease_progression 
H-positive risk:  834 935 136 917 400 117 864 439 116 53 147 42 
H-negative risk:  935 834 864 917 439 400 117 136 147 116 42 53 
New BC onsets:  24
BC status:  4976 24 
BC subtype:  4976 17 7 

clinical_engagement 
diagnosis 
demography 
77 new agents 
16 
disease_progression 
H-positive risk:  843 939 136 911 403 119 865 429 117 51 144 43 
H-negative risk:  939 843 865 911 429 403 119 136 144 117 43 51 
New BC onsets:  29
BC status:  4971 29 
BC subtype:  4971 22 7 

clinical_engagement 
diagnosis 
demography 
58 new agents 
17 
disease_progression 
H-positive risk:  848 937 136 912 402 118 870 428 114 50 144 41 
H-negative risk:  937 848 870 912 428 402 118 136 144 114 41 50 
New BC onsets:  31
BC status:  4969 31 
BC subtype:  4969 22 9 

clinical_engagement 
diagnosis 
demography 
64 new agents 
18 
disease_progression 
H-positive risk:  850 938 135 911 399 118 878 426 115 50 140 40 
H-negative risk:  938 850 878 911 426 399 118 135 140 115 40 50 
New BC onsets:  31
BC status:  4969 31 
BC subtype:  4969 22 9 

clinical_engagement 
diagnosis 
demography 
75 new agents 
19 
disease_progression 
H-positive risk:  852 941 137 916 395 120 872 419 114 56 140 38 
H-negative risk:  941 852 872 916 419 395 120 137 140 114 38 56 
New BC onsets:  35
BC status:  4965 35 
BC subtype:  4965 26 9 

clinical_engagement 
diagnosis 
demography 
76 new agents 
20 
disease_progression 
H-positive risk:  858 944 137 912 385 123 879 417 115 55 136 39 
H-negative risk:  944 858 879 912 417 385 123 137 136 115 39 55 
New BC onsets:  35
BC status:  4965 35 
BC subtype:  4965 26 9 

clinical_engagement 
diagnosis 
demography 
60 new agents 
21 
disease_progression 
H-positive risk:  858 947 137 912 379 125 883 415 115 53 136 40 
H-negative risk:  947 858 883 912 415 379 125 137 136 115 40 53 
New BC onsets:  36
BC status:  4964 36 
BC subtype:  4964 26 10 

clinical_engagement 
diagnosis 
demography 
79 new agents 
22 
disease_progression 
H-positive risk:  870 945 137 914 373 125 887 410 113 51 134 41 
H-negative risk:  945 870 887 914 410 373 125 137 134 113 41 51 
New BC onsets:  40
BC status:  4960 40 
BC subtype:  4960 32 8 

clinical_engagement 
diagnosis 
demography 
82 new agents 
23 
disease_progression 
H-positive risk:  874 954 136 908 369 126 894 401 116 50 131 41 
H-negative risk:  954 874 894 908 401 369 126 136 131 116 41 50 
New BC onsets:  42
BC status:  4958 42 
BC subtype:  4958 33 9 

clinical_engagement 
diagnosis 
demography 
73 new agents 
24 
disease_progression 
H-positive risk:  878 961 134 907 367 126 890 396 118 50 134 39 
H-negative risk:  961 878 890 907 396 367 126 134 134 118 39 50 
New BC onsets:  41
BC status:  4959 41 
BC subtype:  4959 33 8 

clinical_engagement 
diagnosis 
demography 
53 new agents 
25 
disease_progression 
H-positive risk:  817 889 120 978 370 114 951 391 130 51 150 39 
H-negative risk:  889 817 951 978 391 370 114 120 150 130 39 51 
New BC onsets:  42
BC status:  4958 42 
BC subtype:  4958 34 8 

clinical_engagement 
diagnosis 
demography 
192 new agents 
26 
disease_progression 
H-positive risk:  840 911 120 947 381 117 924 395 128 48 138 51 
H-negative risk:  911 840 924 947 395 381 117 120 138 128 51 48 
New BC onsets:  47
BC status:  4953 47 
BC subtype:  4953 39 8 

clinical_engagement 
diagnosis 
demography 
59 new agents 
27 
disease_progression 
H-positive risk:  841 910 121 948 384 120 918 397 128 48 136 49 
H-negative risk:  910 841 918 948 397 384 120 121 136 128 49 48 
New BC onsets:  47
BC status:  4953 47 
BC subtype:  4953 38 9 

clinical_engagement 
diagnosis 
demography 
66 new agents 
28 
disease_progression 
H-positive risk:  841 916 119 940 382 121 928 392 129 47 136 49 
H-negative risk:  916 841 928 940 392 382 121 119 136 129 49 47 
New BC onsets:  50
BC status:  4950 50 
BC subtype:  4950 41 9 

clinical_engagement 
diagnosis 
demography 
56 new agents 
29 
disease_progression 
H-positive risk:  840 910 119 941 384 122 936 386 129 47 137 49 
H-negative risk:  910 840 936 941 386 384 122 119 137 129 49 47 
New BC onsets:  50
BC status:  4950 50 
BC subtype:  4950 41 9 

clinical_engagement 
diagnosis 
demography 
70 new agents 
30 
disease_progression 
H-positive risk:  846 907 121 952 375 124 929 384 132 45 135 50 
H-negative risk:  907 846 929 952 384 375 124 121 135 132 50 45 
New BC onsets:  53
BC status:  4947 53 
BC subtype:  4947 44 9 

clinical_engagement 
diagnosis 
demography 
69 new agents 
31 
disease_progression 
H-positive risk:  856 909 123 950 375 124 921 388 130 43 135 46 
H-negative risk:  909 856 921 950 388 375 124 123 135 130 46 43 
New BC onsets:  55
BC status:  4945 55 
BC subtype:  4945 46 9 

clinical_engagement 
diagnosis 
demography 
61 new agents 
32 
disease_progression 
H-positive risk:  858 914 123 952 374 124 916 385 129 44 135 46 
H-negative risk:  914 858 916 952 385 374 124 123 135 129 46 44 
New BC onsets:  58
BC status:  4942 58 
BC subtype:  4942 49 9 

clinical_engagement 
diagnosis 
demography 
70 new agents 
33 
disease_progression 
H-positive risk:  866 919 122 949 368 123 912 386 133 44 132 46 
H-negative risk:  919 866 912 949 386 368 123 122 132 133 46 44 
New BC onsets:  60
BC status:  4940 60 
BC subtype:  4940 50 10 

clinical_engagement 
diagnosis 
demography 
64 new agents 
34 
disease_progression 
H-positive risk:  869 922 124 949 368 121 912 379 134 45 132 45 
H-negative risk:  922 869 912 949 379 368 121 124 132 134 45 45 
New BC onsets:  60
BC status:  4940 60 
BC subtype:  4940 49 11 

clinical_engagement 
diagnosis 
demography 
59 new agents 
35 
disease_progression 
H-positive risk:  876 927 123 940 370 119 912 378 133 44 130 48 
H-negative risk:  927 876 912 940 378 370 119 123 130 133 48 44 
New BC onsets:  63
BC status:  4937 63 
BC subtype:  4937 52 11 

clinical_engagement 
diagnosis 
demography 
61 new agents 
36 
disease_progression 
H-positive risk:  877 931 126 940 365 122 910 370 137 45 130 47 
H-negative risk:  931 877 910 940 370 365 122 126 130 137 47 45 
New BC onsets:  65
BC status:  4935 65 
BC subtype:  4935 53 12 

clinical_engagement 
diagnosis 
demography 
74 new agents 
37 
disease_progression 
H-positive risk:  817 864 117 1002 367 115 974 370 147 43 138 46 
H-negative risk:  864 817 974 1002 370 367 115 117 138 147 46 43 
New BC onsets:  68
BC status:  4932 68 
BC subtype:  4932 55 13 

clinical_engagement 
diagnosis 
demography 
141 new agents 
38 
disease_progression 
H-positive risk:  838 882 118 964 381 117 941 383 148 45 135 48 
H-negative risk:  882 838 941 964 383 381 117 118 135 148 48 45 
New BC onsets:  71
BC status:  4929 71 
BC subtype:  4929 58 13 

clinical_engagement 
diagnosis 
demography 
73 new agents 
39 
disease_progression 
H-positive risk:  839 881 121 967 372 116 941 386 151 48 134 44 
H-negative risk:  881 839 941 967 386 372 116 121 134 151 44 48 
New BC onsets:  74
BC status:  4926 74 
BC subtype:  4926 59 15 

clinical_engagement 
diagnosis 
demography 
63 new agents 
40 
disease_progression 
H-positive risk:  840 880 118 964 374 117 944 385 153 49 131 45 
H-negative risk:  880 840 944 964 385 374 117 118 131 153 45 49 
New BC onsets:  76
BC status:  4924 76 
BC subtype:  4924 61 15 

clinical_engagement 
diagnosis 
demography 
74 new agents 
41 
disease_progression 
H-positive risk:  838 882 121 964 378 119 945 379 153 46 130 45 
H-negative risk:  882 838 945 964 379 378 119 121 130 153 45 46 
New BC onsets:  77
BC status:  4923 77 
BC subtype:  4923 62 15 

clinical_engagement 
diagnosis 
demography 
78 new agents 
42 
disease_progression 
H-positive risk:  836 880 123 966 376 123 945 373 155 45 133 45 
H-negative risk:  880 836 945 966 373 376 123 123 133 155 45 45 
New BC onsets:  82
BC status:  4918 82 
BC subtype:  4918 65 17 

clinical_engagement 
diagnosis 
demography 
63 new agents 
43 
disease_progression 
H-positive risk:  843 885 125 964 372 123 948 368 152 46 129 45 
H-negative risk:  885 843 948 964 368 372 123 125 129 152 45 46 
New BC onsets:  85
BC status:  4915 85 
BC subtype:  4915 66 19 

clinical_engagement 
diagnosis 
demography 
67 new agents 
44 
disease_progression 
H-positive risk:  847 882 128 971 366 119 956 356 157 46 129 43 
H-negative risk:  882 847 956 971 356 366 119 128 129 157 43 46 
New BC onsets:  86
BC status:  4914 86 
BC subtype:  4914 67 19 

clinical_engagement 
diagnosis 
demography 
54 new agents 
45 
disease_progression 
H-positive risk:  851 876 129 980 360 116 950 361 157 46 130 44 
H-negative risk:  876 851 950 980 361 360 116 129 130 157 44 46 
New BC onsets:  86
BC status:  4914 86 
BC subtype:  4914 66 20 

clinical_engagement 
diagnosis 
demography 
73 new agents 
46 
disease_progression 
H-positive risk:  852 880 129 977 355 114 957 361 156 47 127 45 
H-negative risk:  880 852 957 977 361 355 114 129 127 156 45 47 
New BC onsets:  85
BC status:  4915 85 
BC subtype:  4915 66 19 

clinical_engagement 
diagnosis 
demography 
78 new agents 
47 
disease_progression 
H-positive risk:  863 876 126 986 353 115 951 361 155 47 122 45 
H-negative risk:  876 863 951 986 361 353 115 126 122 155 45 47 
New BC onsets:  83
BC status:  4917 83 
BC subtype:  4917 64 19 

clinical_engagement 
diagnosis 
demography 
60 new agents 
48 
disease_progression 
H-positive risk:  865 879 127 986 350 115 951 364 152 47 121 43 
H-negative risk:  879 865 951 986 364 350 115 127 121 152 43 47 
New BC onsets:  84
BC status:  4916 84 
BC subtype:  4916 64 20 

clinical_engagement 
diagnosis 
demography 
72 new agents 
49 
disease_progression 
H-positive risk:  815 837 120 1030 350 112 1004 367 156 45 125 39 
H-negative risk:  837 815 1004 1030 367 350 112 120 125 156 39 45 
New BC onsets:  86
BC status:  4914 86 
BC subtype:  4914 64 22 

clinical_engagement 
diagnosis 
demography 
126 new agents 
50 
disease_progression 
H-positive risk:  814 835 122 1012 374 112 993 373 151 51 121 42 
H-negative risk:  835 814 993 1012 373 374 112 122 121 151 42 51 
New BC onsets:  84
BC status:  4916 84 
BC subtype:  4916 64 20 

clinical_engagement 
diagnosis 
demography 
75 new agents 
51 
disease_progression 
H-positive risk:  821 841 122 1012 375 115 990 365 149 48 121 41 
H-negative risk:  841 821 990 1012 365 375 115 122 121 149 41 48 
New BC onsets:  87
BC status:  4913 87 
BC subtype:  4913 68 19 

clinical_engagement 
diagnosis 
demography 
68 new agents 
52 
disease_progression 
H-positive risk:  824 842 124 1014 375 115 978 368 147 48 125 40 
H-negative risk:  842 824 978 1014 368 375 115 124 125 147 40 48 
New BC onsets:  87
BC status:  4913 87 
BC subtype:  4913 69 18 

clinical_engagement 
diagnosis 
demography 
69 new agents 
53 
disease_progression 
H-positive risk:  833 847 126 1003 363 115 984 366 149 47 127 40 
H-negative risk:  847 833 984 1003 366 363 115 126 127 149 40 47 
New BC onsets:  87
BC status:  4913 87 
BC subtype:  4913 69 18 

clinical_engagement 
diagnosis 
demography 
64 new agents 
54 
disease_progression 
H-positive risk:  838 847 125 1007 362 114 981 366 147 47 126 40 
H-negative risk:  847 838 981 1007 366 362 114 125 126 147 40 47 
New BC onsets:  88
BC status:  4912 88 
BC subtype:  4912 70 18 

clinical_engagement 
diagnosis 
demography 
69 new agents 
55 
disease_progression 
H-positive risk:  846 850 123 1001 364 113 974 365 149 46 129 40 
H-negative risk:  850 846 974 1001 365 364 113 123 129 149 40 46 
New BC onsets:  86
BC status:  4914 86 
BC subtype:  4914 68 18 

clinical_engagement 
diagnosis 
demography 
51 new agents 
56 
disease_progression 
H-positive risk:  848 852 124 1001 356 116 981 360 148 45 130 39 
H-negative risk:  852 848 981 1001 360 356 116 124 130 148 39 45 
New BC onsets:  87
BC status:  4913 87 
BC subtype:  4913 69 18 

clinical_engagement 
diagnosis 
demography 
70 new agents 
57 
disease_progression 
H-positive risk:  852 856 124 998 359 114 979 360 150 41 130 37 
H-negative risk:  856 852 979 998 360 359 114 124 130 150 37 41 
New BC onsets:  88
BC status:  4912 88 
BC subtype:  4912 69 19 

clinical_engagement 
diagnosis 
demography 
63 new agents 
58 
disease_progression 
H-positive risk:  853 859 126 995 361 116 973 361 150 40 130 36 
H-negative risk:  859 853 973 995 361 361 116 126 130 150 36 40 
New BC onsets:  89
BC status:  4911 89 
BC subtype:  4911 69 20 

clinical_engagement 
diagnosis 
demography 
56 new agents 
59 
disease_progression 
H-positive risk:  854 859 125 992 361 115 974 361 153 39 131 36 
H-negative risk:  859 854 974 992 361 361 115 125 131 153 36 39 
New BC onsets:  91
BC status:  4909 91 
BC subtype:  4909 71 20 

clinical_engagement 
diagnosis 
demography 
71 new agents 
60 
disease_progression 
H-positive risk:  860 857 125 994 356 116 976 354 152 38 135 37 
H-negative risk:  857 860 976 994 354 356 116 125 135 152 37 38 
New BC onsets:  91
BC status:  4909 91 
BC subtype:  4909 70 21 

clinical_engagement 
diagnosis 
demography 
56 new agents 
61 
disease_progression 
H-positive risk:  812 801 120 1044 359 112 1025 356 155 38 142 36 
H-negative risk:  801 812 1025 1044 356 359 112 120 142 155 36 38 
New BC onsets:  89
BC status:  4911 89 
BC subtype:  4911 68 21 

clinical_engagement 
diagnosis 
demography 
125 new agents 
62 
disease_progression 
H-positive risk:  821 797 120 1034 365 115 1003 369 150 45 145 36 
H-negative risk:  797 821 1003 1034 369 365 115 120 145 150 36 45 
New BC onsets:  92
BC status:  4908 92 
BC subtype:  4908 71 21 

clinical_engagement 
diagnosis 
demography 
64 new agents 
63 
disease_progression 
H-positive risk:  825 795 120 1031 369 119 991 376 146 45 146 37 
H-negative risk:  795 825 991 1031 376 369 119 120 146 146 37 45 
New BC onsets:  91
BC status:  4909 91 
BC subtype:  4909 71 20 

clinical_engagement 
diagnosis 
demography 
67 new agents 
64 
disease_progression 
H-positive risk:  828 796 120 1039 363 118 989 373 146 45 147 36 
H-negative risk:  796 828 989 1039 373 363 118 120 147 146 36 45 
New BC onsets:  92
BC status:  4908 92 
BC subtype:  4908 72 20 

clinical_engagement 
diagnosis 
demography 
65 new agents 
65 
disease_progression 
H-positive risk:  838 788 121 1039 364 115 985 368 149 45 149 39 
H-negative risk:  788 838 985 1039 368 364 115 121 149 149 39 45 
New BC onsets:  92
BC status:  4908 92 
BC subtype:  4908 72 20 

clinical_engagement 
diagnosis 
demography 
73 new agents 
66 
disease_progression 
H-positive risk:  844 786 120 1043 359 113 987 367 149 45 151 36 
H-negative risk:  786 844 987 1043 367 359 113 120 151 149 36 45 
New BC onsets:  97
BC status:  4903 97 
BC subtype:  4903 75 22 

clinical_engagement 
diagnosis 
demography 
68 new agents 
67 
disease_progression 
H-positive risk:  845 788 121 1050 359 114 986 362 145 44 151 35 
H-negative risk:  788 845 986 1050 362 359 114 121 151 145 35 44 
New BC onsets:  98
BC status:  4902 98 
BC subtype:  4902 76 22 

clinical_engagement 
diagnosis 
demography 
68 new agents 
68 
disease_progression 
H-positive risk:  844 783 119 1069 353 111 986 363 142 45 151 34 
H-negative risk:  783 844 986 1069 363 353 111 119 151 142 34 45 
New BC onsets:  98
BC status:  4902 98 
BC subtype:  4902 75 23 

clinical_engagement 
diagnosis 
demography 
62 new agents 
69 
disease_progression 
H-positive risk:  843 784 119 1064 360 109 984 364 142 46 151 34 
H-negative risk:  784 843 984 1064 364 360 109 119 151 142 34 46 
New BC onsets:  99
BC status:  4901 99 
BC subtype:  4901 74 25 

clinical_engagement 
diagnosis 
demography 
76 new agents 
70 
disease_progression 
H-positive risk:  840 785 119 1059 361 110 989 360 145 48 150 34 
H-negative risk:  785 840 989 1059 360 361 110 119 150 145 34 48 
New BC onsets:  98
BC status:  4902 98 
BC subtype:  4902 73 25 

clinical_engagement 
diagnosis 
demography 
62 new agents 
71 
disease_progression 
H-positive risk:  839 783 120 1058 355 111 988 366 145 48 151 36 
H-negative risk:  783 839 988 1058 366 355 111 120 151 145 36 48 
New BC onsets:  103
BC status:  4897 103 
BC subtype:  4897 78 25 

clinical_engagement 
diagnosis 
demography 
55 new agents 
72 
disease_progression 
H-positive risk:  836 792 120 1045 359 111 982 372 143 49 155 36 
H-negative risk:  792 836 982 1045 372 359 111 120 155 143 36 49 
New BC onsets:  106
BC status:  4894 106 
BC subtype:  4894 81 25 

clinical_engagement 
diagnosis 
demography 
66 new agents 
73 
disease_progression 
H-positive risk:  780 750 116 1087 362 105 1039 365 149 51 161 35 
H-negative risk:  750 780 1039 1087 365 362 105 116 161 149 35 51 
New BC onsets:  106
BC status:  4894 106 
BC subtype:  4894 81 25 

clinical_engagement 
diagnosis 
demography 
111 new agents 
74 
disease_progression 
H-positive risk:  783 754 113 1066 370 105 1024 387 149 51 158 40 
H-negative risk:  754 783 1024 1066 387 370 105 113 158 149 40 51 
New BC onsets:  103
BC status:  4897 103 
BC subtype:  4897 78 25 

clinical_engagement 
diagnosis 
demography 
75 new agents 
75 
disease_progression 
H-positive risk:  788 756 114 1067 366 105 1027 386 149 49 154 39 
H-negative risk:  756 788 1027 1067 386 366 105 114 154 149 39 49 
New BC onsets:  103
BC status:  4897 103 
BC subtype:  4897 78 25 

clinical_engagement 
diagnosis 
demography 
68 new agents 
76 
disease_progression 
H-positive risk:  785 755 116 1069 365 104 1032 381 151 49 153 40 
H-negative risk:  755 785 1032 1069 381 365 104 116 153 151 40 49 
New BC onsets:  106
BC status:  4894 106 
BC subtype:  4894 81 25 

clinical_engagement 
diagnosis 
demography 
73 new agents 
77 
disease_progression 
H-positive risk:  792 754 116 1070 354 103 1038 375 153 52 155 38 
H-negative risk:  754 792 1038 1070 375 354 103 116 155 153 38 52 
New BC onsets:  109
BC status:  4891 109 
BC subtype:  4891 84 25 

clinical_engagement 
diagnosis 
demography 
85 new agents 
78 
disease_progression 
H-positive risk:  794 765 114 1066 347 103 1031 377 154 51 155 43 
H-negative risk:  765 794 1031 1066 377 347 103 114 155 154 43 51 
New BC onsets:  110
BC status:  4890 110 
BC subtype:  4890 83 27 

clinical_engagement 
diagnosis 
demography 
67 new agents 
79 
disease_progression 
H-positive risk:  785 767 116 1057 352 103 1041 378 154 53 153 41 
H-negative risk:  767 785 1041 1057 378 352 103 116 153 154 41 53 
New BC onsets:  109
BC status:  4891 109 
BC subtype:  4891 82 27 

clinical_engagement 
diagnosis 
demography 
60 new agents 
80 
disease_progression 
H-positive risk:  781 775 115 1050 357 105 1037 379 154 53 153 41 
H-negative risk:  775 781 1037 1050 379 357 105 115 153 154 41 53 
New BC onsets:  106
BC status:  4894 106 
BC subtype:  4894 79 27 

clinical_engagement 
diagnosis 
demography 
75 new agents 
81 
disease_progression 
H-positive risk:  782 783 113 1043 359 104 1036 378 151 55 154 42 
H-negative risk:  783 782 1036 1043 378 359 104 113 154 151 42 55 
New BC onsets:  106
BC status:  4894 106 
BC subtype:  4894 79 27 

clinical_engagement 
diagnosis 
demography 
59 new agents 
82 
disease_progression 
H-positive risk:  776 783 109 1042 362 111 1039 381 149 55 152 41 
H-negative risk:  783 776 1039 1042 381 362 111 109 152 149 41 55 
New BC onsets:  100
BC status:  4900 100 
BC subtype:  4900 74 26 

clinical_engagement 
diagnosis 
demography 
69 new agents 
83 
disease_progression 
H-positive risk:  780 780 110 1047 356 115 1037 379 148 55 152 41 
H-negative risk:  780 780 1037 1047 379 356 115 110 152 148 41 55 
New BC onsets:  101
BC status:  4899 101 
BC subtype:  4899 75 26 

clinical_engagement 
diagnosis 
demography 
77 new agents 
84 
disease_progression 
H-positive risk:  778 783 109 1050 344 116 1038 386 147 55 152 42 
H-negative risk:  783 778 1038 1050 386 344 116 109 152 147 42 55 
New BC onsets:  98
BC status:  4902 98 
BC subtype:  4902 73 25 

clinical_engagement 
diagnosis 
demography 
63 new agents 
85 
disease_progression 
H-positive risk:  730 735 101 1106 337 109 1080 386 155 57 162 42 
H-negative risk:  735 730 1080 1106 386 337 109 101 162 155 42 57 
New BC onsets:  98
BC status:  4902 98 
BC subtype:  4902 75 23 

clinical_engagement 
diagnosis 
demography 
96 new agents 
86 
disease_progression 
H-positive risk:  732 740 100 1075 367 110 1073 392 152 57 156 46 
H-negative risk:  740 732 1073 1075 392 367 110 100 156 152 46 57 
New BC onsets:  99
BC status:  4901 99 
BC subtype:  4901 76 23 

clinical_engagement 
diagnosis 
demography 
78 new agents 
87 
disease_progression 
H-positive risk:  738 745 100 1064 370 111 1062 399 151 59 152 49 
H-negative risk:  745 738 1062 1064 399 370 111 100 152 151 49 59 
New BC onsets:  100
BC status:  4900 100 
BC subtype:  4900 77 23 

clinical_engagement 
diagnosis 
demography 
72 new agents 
88 
disease_progression 
H-positive risk:  733 751 101 1065 367 110 1065 398 151 56 151 52 
H-negative risk:  751 733 1065 1065 398 367 110 101 151 151 52 56 
New BC onsets:  103
BC status:  4897 103 
BC subtype:  4897 79 24 

clinical_engagement 
diagnosis 
demography 
71 new agents 
89 
disease_progression 
H-positive risk:  736 753 99 1068 367 110 1060 396 153 55 151 52 
H-negative risk:  753 736 1060 1068 396 367 110 99 151 153 52 55 
New BC onsets:  103
BC status:  4897 103 
BC subtype:  4897 78 25 

clinical_engagement 
diagnosis 
demography 
57 new agents 
90 
disease_progression 
H-positive risk:  733 750 96 1072 370 113 1056 395 153 60 150 52 
H-negative risk:  750 733 1056 1072 395 370 113 96 150 153 52 60 
New BC onsets:  100
BC status:  4900 100 
BC subtype:  4900 75 25 

clinical_engagement 
diagnosis 
demography 
61 new agents 
91 
disease_progression 
H-positive risk:  733 751 95 1078 366 111 1056 396 152 59 149 54 
H-negative risk:  751 733 1056 1078 396 366 111 95 149 152 54 59 
New BC onsets:  98
BC status:  4902 98 
BC subtype:  4902 73 25 

clinical_engagement 
diagnosis 
demography 
77 new agents 
92 
disease_progression 
H-positive risk:  736 762 97 1076 358 111 1052 397 151 59 146 55 
H-negative risk:  762 736 1052 1076 397 358 111 97 146 151 55 59 
New BC onsets:  97
BC status:  4903 97 
BC subtype:  4903 73 24 

clinical_engagement 
diagnosis 
demography 
61 new agents 
93 
disease_progression 
H-positive risk:  740 756 99 1075 356 111 1059 391 149 61 146 57 
H-negative risk:  756 740 1059 1075 391 356 111 99 146 149 57 61 
New BC onsets:  96
BC status:  4904 96 
BC subtype:  4904 72 24 

clinical_engagement 
diagnosis 
demography 
88 new agents 
94 
disease_progression 
H-positive risk:  749 751 100 1081 357 111 1057 383 146 63 145 57 
H-negative risk:  751 749 1057 1081 383 357 111 100 145 146 57 63 
New BC onsets:  98
BC status:  4902 98 
BC subtype:  4902 76 22 

clinical_engagement 
diagnosis 
demography 
79 new agents 
95 
disease_progression 
H-positive risk:  758 750 98 1072 358 112 1063 379 146 62 143 59 
H-negative risk:  750 758 1063 1072 379 358 112 98 143 146 59 62 
New BC onsets:  99
BC status:  4901 99 
BC subtype:  4901 78 21 

clinical_engagement 
diagnosis 
demography 
65 new agents 
96 
disease_progression 
H-positive risk:  761 757 95 1063 354 114 1062 384 147 61 146 56 
H-negative risk:  757 761 1062 1063 384 354 114 95 146 147 56 61 
New BC onsets:  96
BC status:  4904 96 
BC subtype:  4904 76 20 

clinical_engagement 
diagnosis 
demography 
59 new agents 
97 
disease_progression 
H-positive risk:  729 698 93 1119 355 109 1095 383 155 60 148 56 
H-negative risk:  698 729 1095 1119 383 355 109 93 148 155 56 60 
New BC onsets:  97
BC status:  4903 97 
BC subtype:  4903 78 19 

clinical_engagement 
diagnosis 
demography 
94 new agents 
98 
disease_progression 
H-positive risk:  745 696 95 1096 371 110 1067 400 152 65 143 60 
H-negative risk:  696 745 1067 1096 400 371 110 95 143 152 60 65 
New BC onsets:  95
BC status:  4905 95 
BC subtype:  4905 77 18 

clinical_engagement 
diagnosis 
demography 
110 new agents 
99 
disease_progression 
H-positive risk:  749 703 98 1098 370 112 1065 391 150 59 145 60 
H-negative risk:  703 749 1065 1098 391 370 112 98 145 150 60 59 
New BC onsets:  96
BC status:  4904 96 
BC subtype:  4904 76 20 

clinical_engagement 
diagnosis 
demography 
76 new agents 
100 
disease_progression 
H-positive risk:  749 707 99 1089 378 115 1064 384 152 58 146 59 
H-negative risk:  707 749 1064 1089 384 378 115 99 146 152 59 58 
New BC onsets:  97
BC status:  4903 97 
BC subtype:  4903 77 20 

clinical_engagement 
diagnosis 
demography 
64 new agents 
101 
disease_progression 
H-positive risk:  750 715 97 1090 368 115 1061 387 149 63 144 61 
H-negative risk:  715 750 1061 1090 387 368 115 97 144 149 61 63 
New BC onsets:  98
BC status:  4902 98 
BC subtype:  4902 77 21 

clinical_engagement 
diagnosis 
demography 
69 new agents 
102 
disease_progression 
H-positive risk:  742 716 97 1091 366 116 1066 385 146 64 149 62 
H-negative risk:  716 742 1066 1091 385 366 116 97 149 146 62 64 
New BC onsets:  98
BC status:  4902 98 
BC subtype:  4902 77 21 

clinical_engagement 
diagnosis 
demography 
74 new agents 
103 
disease_progression 
H-positive risk:  747 721 95 1090 375 113 1063 379 148 62 145 62 
H-negative risk:  721 747 1063 1090 379 375 113 95 145 148 62 62 
New BC onsets:  101
BC status:  4899 101 
BC subtype:  4899 80 21 

clinical_engagement 
diagnosis 
demography 
52 new agents 
104 
disease_progression 
H-positive risk:  747 723 91 1087 379 112 1061 382 147 59 151 61 
H-negative risk:  723 747 1061 1087 382 379 112 91 151 147 61 59 
New BC onsets:  106
BC status:  4894 106 
BC subtype:  4894 83 23 

clinical_engagement 
diagnosis 
demography 
81 new agents 
105 
disease_progression 
H-positive risk:  760 721 91 1067 379 112 1056 390 149 60 154 61 
H-negative risk:  721 760 1056 1067 390 379 112 91 154 149 61 60 
New BC onsets:  104
BC status:  4896 104 
BC subtype:  4896 82 22 

clinical_engagement 
diagnosis 
demography 
64 new agents 
106 
disease_progression 
H-positive risk:  750 717 94 1071 377 107 1066 391 150 61 155 61 
H-negative risk:  717 750 1066 1071 391 377 107 94 155 150 61 61 
New BC onsets:  103
BC status:  4897 103 
BC subtype:  4897 81 22 

clinical_engagement 
diagnosis 
demography 
68 new agents 
107 
disease_progression 
H-positive risk:  747 717 96 1069 381 108 1066 387 149 62 157 61 
H-negative risk:  717 747 1066 1069 387 381 108 96 157 149 61 62 
New BC onsets:  104
BC status:  4896 104 
BC subtype:  4896 79 25 

clinical_engagement 
diagnosis 
demography 
63 new agents 
108 
disease_progression 
H-positive risk:  752 720 97 1065 381 108 1060 389 149 61 157 61 
H-negative risk:  720 752 1060 1065 389 381 108 97 157 149 61 61 
New BC onsets:  103
BC status:  4897 103 
BC subtype:  4897 78 25 

clinical_engagement 
diagnosis 
demography 
84 new agents 
109 
disease_progression 
H-positive risk:  708 686 93 1100 379 102 1111 384 157 61 162 57 
H-negative risk:  686 708 1111 1100 384 379 102 93 162 157 57 61 
New BC onsets:  101
BC status:  4899 101 
BC subtype:  4899 77 24 

clinical_engagement 
diagnosis 
demography 
96 new agents 
110 
disease_progression 
H-positive risk:  706 669 93 1114 390 103 1106 392 150 60 161 56 
H-negative risk:  669 706 1106 1114 392 390 103 93 161 150 56 60 
New BC onsets:  96
BC status:  4904 96 
BC subtype:  4904 72 24 

clinical_engagement 
diagnosis 
demography 
97 new agents 
111 
disease_progression 
H-positive risk:  706 669 93 1109 395 106 1106 393 150 54 162 57 
H-negative risk:  669 706 1106 1109 393 395 106 93 162 150 57 54 
New BC onsets:  99
BC status:  4901 99 
BC subtype:  4901 75 24 

clinical_engagement 
diagnosis 
demography 
67 new agents 
112 
disease_progression 
H-positive risk:  712 668 93 1108 400 106 1097 396 151 54 159 56 
H-negative risk:  668 712 1097 1108 396 400 106 93 159 151 56 54 
New BC onsets:  99
BC status:  4901 99 
BC subtype:  4901 75 24 

clinical_engagement 
diagnosis 
demography 
81 new agents 
113 
disease_progression 
H-positive risk:  713 672 89 1108 393 107 1109 392 148 54 163 52 
H-negative risk:  672 713 1109 1108 392 393 107 89 163 148 52 54 
New BC onsets:  101
BC status:  4899 101 
BC subtype:  4899 75 26 

clinical_engagement 
diagnosis 
demography 
74 new agents 
114 
disease_progression 
H-positive risk:  719 668 89 1116 388 108 1108 392 147 55 159 51 
H-negative risk:  668 719 1108 1116 392 388 108 89 159 147 51 55 
New BC onsets:  100
BC status:  4900 100 
BC subtype:  4900 74 26 

clinical_engagement 
diagnosis 
demography 
67 new agents 
115 
disease_progression 
H-positive risk:  713 675 91 1105 391 111 1118 387 150 54 154 51 
H-negative risk:  675 713 1118 1105 387 391 111 91 154 150 51 54 
New BC onsets:  99
BC status:  4901 99 
BC subtype:  4901 71 28 

clinical_engagement 
diagnosis 
demography 
55 new agents 
116 
disease_progression 
H-positive risk:  712 676 90 1110 388 111 1118 386 151 55 153 50 
H-negative risk:  676 712 1118 1110 386 388 111 90 153 151 50 55 
New BC onsets:  96
BC status:  4904 96 
BC subtype:  4904 69 27 

clinical_engagement 
diagnosis 
demography 
57 new agents 
117 
disease_progression 
H-positive risk:  718 674 86 1117 387 110 1113 387 149 57 152 50 
H-negative risk:  674 718 1113 1117 387 387 110 86 152 149 50 57 
New BC onsets:  97
BC status:  4903 97 
BC subtype:  4903 66 31 

clinical_engagement 
diagnosis 
demography 
74 new agents 
118 
disease_progression 
H-positive risk:  720 677 83 1127 380 110 1112 385 149 55 154 48 
H-negative risk:  677 720 1112 1127 385 380 110 83 154 149 48 55 
New BC onsets:  99
BC status:  4901 99 
BC subtype:  4901 68 31 

clinical_engagement 
diagnosis 
demography 
80 new agents 
119 
disease_progression 
H-positive risk:  715 678 82 1128 377 110 1111 391 149 57 153 49 
H-negative risk:  678 715 1111 1128 391 377 110 82 153 149 49 57 
New BC onsets:  98
BC status:  4902 98 
BC subtype:  4902 69 29 

clinical_engagement 
diagnosis 
demography 
63 new agents 
120 
disease_progression 
H-positive risk:  718 680 82 1130 372 112 1109 386 150 57 153 51 
H-negative risk:  680 718 1109 1130 386 372 112 82 153 150 51 57 
New BC onsets:  97
BC status:  4903 97 
BC subtype:  4903 68 29 

clinical_engagement 
diagnosis 
demography 
73 new agents 
121 
disease_progression 
H-positive risk:  679 654 69 1159 370 107 1151 383 157 54 166 51 
H-negative risk:  654 679 1151 1159 383 370 107 69 166 157 51 54 
New BC onsets:  97
BC status:  4903 97 
BC subtype:  4903 69 28 

clinical_engagement 
diagnosis 
demography 
89 new agents 
122 
disease_progression 
H-positive risk:  683 651 71 1148 381 110 1143 387 154 53 161 58 
H-negative risk:  651 683 1143 1148 387 381 110 71 161 154 58 53 
New BC onsets:  101
BC status:  4899 101 
BC subtype:  4899 69 32 

clinical_engagement 
diagnosis 
demography 
76 new agents 
123 
disease_progression 
H-positive risk:  674 658 71 1137 382 105 1147 392 158 53 164 59 
H-negative risk:  658 674 1147 1137 392 382 105 71 164 158 59 53 
New BC onsets:  100
BC status:  4900 100 
BC subtype:  4900 67 33 

clinical_engagement 
diagnosis 
demography 
94 new agents 
124 
disease_progression 
H-positive risk:  682 664 70 1129 377 107 1156 384 157 52 167 55 
H-negative risk:  664 682 1156 1129 384 377 107 70 167 157 55 52 
New BC onsets:  102
BC status:  4898 102 
BC subtype:  4898 67 35 

clinical_engagement 
diagnosis 
demography 
79 new agents 
125 
disease_progression 
H-positive risk:  685 657 71 1130 370 111 1160 386 155 52 167 56 
H-negative risk:  657 685 1160 1130 386 370 111 71 167 155 56 52 
New BC onsets:  100
BC status:  4900 100 
BC subtype:  4900 67 33 

clinical_engagement 
diagnosis 
demography 
55 new agents 
126 
disease_progression 
H-positive risk:  680 652 71 1135 364 109 1164 390 158 52 170 55 
H-negative risk:  652 680 1164 1135 390 364 109 71 170 158 55 52 
New BC onsets:  104
BC status:  4896 104 
BC subtype:  4896 72 32 

clinical_engagement 
diagnosis 
demography 
80 new agents 
127 
disease_progression 
H-positive risk:  682 653 72 1136 361 109 1165 388 158 51 170 55 
H-negative risk:  653 682 1165 1136 388 361 109 72 170 158 55 51 
New BC onsets:  107
BC status:  4893 107 
BC subtype:  4893 75 32 

clinical_engagement 
diagnosis 
demography 
78 new agents 
128 
disease_progression 
H-positive risk:  690 656 72 1135 358 107 1159 391 155 50 171 56 
H-negative risk:  656 690 1159 1135 391 358 107 72 171 155 56 50 
New BC onsets:  104
BC status:  4896 104 
BC subtype:  4896 75 29 

clinical_engagement 
diagnosis 
demography 
54 new agents 
129 
disease_progression 
H-positive risk:  688 660 72 1133 353 107 1167 386 154 51 173 56 
H-negative risk:  660 688 1167 1133 386 353 107 72 173 154 56 51 
New BC onsets:  106
BC status:  4894 106 
BC subtype:  4894 75 31 

clinical_engagement 
diagnosis 
demography 
69 new agents 
130 
disease_progression 
H-positive risk:  688 665 74 1135 356 106 1163 385 154 49 169 56 
H-negative risk:  665 688 1163 1135 385 356 106 74 169 154 56 49 
New BC onsets:  103
BC status:  4897 103 
BC subtype:  4897 74 29 

clinical_engagement 
diagnosis 
demography 
79 new agents 
131 
disease_progression 
H-positive risk:  695 664 76 1135 355 106 1155 388 150 47 171 58 
H-negative risk:  664 695 1155 1135 388 355 106 76 171 150 58 47 
New BC onsets:  100
BC status:  4900 100 
BC subtype:  4900 71 29 

clinical_engagement 
diagnosis 
demography 
53 new agents 
132 
disease_progression 
H-positive risk:  686 667 74 1119 361 106 1163 393 155 48 170 58 
H-negative risk:  667 686 1163 1119 393 361 106 74 170 155 58 48 
New BC onsets:  101
BC status:  4899 101 
BC subtype:  4899 72 29 

clinical_engagement 
diagnosis 
demography 
77 new agents 
133 
disease_progression 
H-positive risk:  695 674 74 1130 356 103 1155 386 155 45 168 59 
H-negative risk:  674 695 1155 1130 386 356 103 74 168 155 59 45 
New BC onsets:  99
BC status:  4901 99 
BC subtype:  4901 72 27 

clinical_engagement 
diagnosis 
demography 
82 new agents 
134 
disease_progression 
H-positive risk:  693 676 74 1111 371 102 1149 390 157 47 166 64 
H-negative risk:  676 693 1149 1111 390 371 102 74 166 157 64 47 
New BC onsets:  96
BC status:  4904 96 
BC subtype:  4904 69 27 

clinical_engagement 
diagnosis 
demography 
74 new agents 
135 
disease_progression 
H-positive risk:  694 671 75 1112 368 102 1154 386 157 48 168 65 
H-negative risk:  671 694 1154 1112 386 368 102 75 168 157 65 48 
New BC onsets:  97
BC status:  4903 97 
BC subtype:  4903 69 28 

clinical_engagement 
diagnosis 
demography 
74 new agents 
136 
disease_progression 
H-positive risk:  680 670 76 1113 365 101 1174 384 155 49 167 66 
H-negative risk:  670 680 1174 1113 384 365 101 76 167 155 66 49 
New BC onsets:  96
BC status:  4904 96 
BC subtype:  4904 70 26 

clinical_engagement 
diagnosis 
demography 
71 new agents 
137 
disease_progression 
H-positive risk:  685 666 76 1117 358 100 1173 387 159 47 166 66 
H-negative risk:  666 685 1173 1117 387 358 100 76 166 159 66 47 
New BC onsets:  96
BC status:  4904 96 
BC subtype:  4904 68 28 

clinical_engagement 
diagnosis 
demography 
71 new agents 
138 
disease_progression 
H-positive risk:  687 672 76 1112 353 98 1170 389 162 47 168 66 
H-negative risk:  672 687 1170 1112 389 353 98 76 168 162 66 47 
New BC onsets:  96
BC status:  4904 96 
BC subtype:  4904 68 28 

clinical_engagement 
diagnosis 
demography 
87 new agents 
139 
disease_progression 
H-positive risk:  687 667 78 1113 358 98 1168 393 163 45 165 65 
H-negative risk:  667 687 1168 1113 393 358 98 78 165 163 65 45 
New BC onsets:  97
BC status:  4903 97 
BC subtype:  4903 68 29 

clinical_engagement 
diagnosis 
demography 
68 new agents 
140 
disease_progression 
H-positive risk:  693 663 76 1102 361 99 1175 390 163 44 168 66 
H-negative risk:  663 693 1175 1102 390 361 99 76 168 163 66 44 
New BC onsets:  91
BC status:  4909 91 
BC subtype:  4909 61 30 

clinical_engagement 
diagnosis 
demography 
75 new agents 
141 
disease_progression 
H-positive risk:  693 664 79 1097 370 101 1168 390 161 45 166 66 
H-negative risk:  664 693 1168 1097 390 370 101 79 166 161 66 45 
New BC onsets:  93
BC status:  4907 93 
BC subtype:  4907 63 30 

clinical_engagement 
diagnosis 
demography 
67 new agents 
142 
disease_progression 
H-positive risk:  688 661 77 1106 371 100 1172 389 162 45 166 63 
H-negative risk:  661 688 1172 1106 389 371 100 77 166 162 63 45 
New BC onsets:  96
BC status:  4904 96 
BC subtype:  4904 66 30 

clinical_engagement 
diagnosis 
demography 
97 new agents 
143 
disease_progression 
H-positive risk:  702 659 76 1108 374 100 1164 383 159 44 167 64 
H-negative risk:  659 702 1164 1108 383 374 100 76 167 159 64 44 
New BC onsets:  100
BC status:  4900 100 
BC subtype:  4900 64 36 

clinical_engagement 
diagnosis 
demography 
81 new agents 
144 
disease_progression 
H-positive risk:  705 666 77 1114 371 95 1154 389 163 44 162 60 
H-negative risk:  666 705 1154 1114 389 371 95 77 162 163 60 44 
New BC onsets:  98
BC status:  4902 98 
BC subtype:  4902 63 35 

clinical_engagement 
diagnosis 
demography 
63 new agents 
145 
disease_progression 
H-positive risk:  703 660 78 1124 372 97 1155 387 161 43 159 61 
H-negative risk:  660 703 1155 1124 387 372 97 78 159 161 61 43 
New BC onsets:  99
BC status:  4901 99 
BC subtype:  4901 64 35 

clinical_engagement 
diagnosis 
demography 
96 new agents 
146 
disease_progression 
H-positive risk:  703 661 83 1110 364 97 1153 389 170 46 161 63 
H-negative risk:  661 703 1153 1110 389 364 97 83 161 170 63 46 
New BC onsets:  98
BC status:  4902 98 
BC subtype:  4902 67 31 

clinical_engagement 
diagnosis 
demography 
77 new agents 
147 
disease_progression 
H-positive risk:  706 663 86 1106 366 94 1139 399 172 47 160 62 
H-negative risk:  663 706 1139 1106 399 366 94 86 160 172 62 47 
New BC onsets:  95
BC status:  4905 95 
BC subtype:  4905 65 30 

clinical_engagement 
diagnosis 
demography 
60 new agents 
148 
disease_progression 
H-positive risk:  710 659 85 1104 378 96 1142 390 170 48 158 60 
H-negative risk:  659 710 1142 1104 390 378 96 85 158 170 60 48 
New BC onsets:  97
BC status:  4903 97 
BC subtype:  4903 67 30 

clinical_engagement 
diagnosis 
demography 
73 new agents 
149 
disease_progression 
H-positive risk:  706 659 86 1112 377 98 1143 386 170 47 158 58 
H-negative risk:  659 706 1143 1112 386 377 98 86 158 170 58 47 
New BC onsets:  99
BC status:  4901 99 
BC subtype:  4901 67 32 

clinical_engagement 
diagnosis 
demography 
74 new agents 
150 
disease_progression 
H-positive risk:  709 653 87 1107 380 98 1140 384 171 49 163 59 
H-negative risk:  653 709 1140 1107 384 380 98 87 163 171 59 49 
New BC onsets:  101
BC status:  4899 101 
BC subtype:  4899 70 31 

clinical_engagement 
diagnosis 
demography 
58 new agents 
151 
disease_progression 
H-positive risk:  707 651 87 1104 386 99 1142 381 174 47 161 61 
H-negative risk:  651 707 1142 1104 381 386 99 87 161 174 61 47 
New BC onsets:  104
BC status:  4896 104 
BC subtype:  4896 73 31 

clinical_engagement 
diagnosis 
demography 
79 new agents 
152 
disease_progression 
H-positive risk:  706 649 88 1112 379 100 1141 385 175 47 157 61 
H-negative risk:  649 706 1141 1112 385 379 100 88 157 175 61 47 
New BC onsets:  102
BC status:  4898 102 
BC subtype:  4898 69 33 

clinical_engagement 
diagnosis 
demography 
85 new agents 
153 
disease_progression 
H-positive risk:  710 650 91 1104 378 100 1149 381 174 49 154 60 
H-negative risk:  650 710 1149 1104 381 378 100 91 154 174 60 49 
New BC onsets:  101
BC status:  4899 101 
BC subtype:  4899 68 33 

clinical_engagement 
diagnosis 
demography 
74 new agents 
154 
disease_progression 
H-positive risk:  716 655 92 1103 378 97 1142 379 175 50 153 60 
H-negative risk:  655 716 1142 1103 379 378 97 92 153 175 60 50 
New BC onsets:  101
BC status:  4899 101 
BC subtype:  4899 69 32 

clinical_engagement 
diagnosis 
demography 
78 new agents 
155 
disease_progression 
H-positive risk:  717 656 88 1100 371 97 1148 380 174 52 159 58 
H-negative risk:  656 717 1148 1100 380 371 97 88 159 174 58 52 
New BC onsets:  101
BC status:  4899 101 
BC subtype:  4899 70 31 

clinical_engagement 
diagnosis 
demography 
73 new agents 
156 
disease_progression 
H-positive risk:  717 655 89 1098 375 93 1159 376 174 52 156 56 
H-negative risk:  655 717 1159 1098 376 375 93 89 156 174 56 52 
New BC onsets:  103
BC status:  4897 103 
BC subtype:  4897 72 31 

clinical_engagement 
diagnosis 
demography 
65 new agents 
157 
disease_progression 
H-positive risk:  716 658 88 1093 373 95 1157 378 176 53 156 57 
H-negative risk:  658 716 1157 1093 378 373 95 88 156 176 57 53 
New BC onsets:  104
BC status:  4896 104 
BC subtype:  4896 73 31 

clinical_engagement 
diagnosis 
demography 
100 new agents 
158 
disease_progression 
H-positive risk:  721 662 89 1080 376 96 1146 391 174 54 155 56 
H-negative risk:  662 721 1146 1080 391 376 96 89 155 174 56 54 
New BC onsets:  107
BC status:  4893 107 
BC subtype:  4893 74 33 

clinical_engagement 
diagnosis 
demography 
81 new agents 
159 
disease_progression 
H-positive risk:  735 661 87 1092 376 94 1130 391 175 52 151 56 
H-negative risk:  661 735 1130 1092 391 376 94 87 151 175 56 52 
New BC onsets:  109
BC status:  4891 109 
BC subtype:  4891 77 32 

clinical_engagement 
diagnosis 
demography 
71 new agents 
160 
disease_progression 
H-positive risk:  738 667 87 1076 386 93 1124 392 178 51 151 57 
H-negative risk:  667 738 1124 1076 392 386 93 87 151 178 57 51 
New BC onsets:  109
BC status:  4891 109 
BC subtype:  4891 79 30 

clinical_engagement 
diagnosis 
demography 
72 new agents 
161 
disease_progression 
H-positive risk:  735 670 87 1074 387 92 1130 394 180 50 145 56 
H-negative risk:  670 735 1130 1074 394 387 92 87 145 180 56 50 
New BC onsets:  113
BC status:  4887 113 
BC subtype:  4887 79 34 

clinical_engagement 
diagnosis 
demography 
62 new agents 
162 
disease_progression 
H-positive risk:  734 668 87 1065 391 93 1132 396 179 51 148 56 
H-negative risk:  668 734 1132 1065 396 391 93 87 148 179 56 51 
New BC onsets:  115
BC status:  4885 115 
BC subtype:  4885 81 34 

clinical_engagement 
diagnosis 
demography 
87 new agents 
163 
disease_progression 
H-positive risk:  739 672 87 1069 383 91 1137 390 178 52 147 55 
H-negative risk:  672 739 1137 1069 390 383 91 87 147 178 55 52 
New BC onsets:  116
BC status:  4884 116 
BC subtype:  4884 81 35 

clinical_engagement 
diagnosis 
demography 
61 new agents 
164 
disease_progression 
H-positive risk:  740 672 89 1067 380 94 1137 394 175 54 144 54 
H-negative risk:  672 740 1137 1067 394 380 94 89 144 175 54 54 
New BC onsets:  115
BC status:  4885 115 
BC subtype:  4885 82 33 

clinical_engagement 
diagnosis 
demography 
68 new agents 
165 
disease_progression 
H-positive risk:  735 675 89 1063 381 93 1148 390 175 53 146 52 
H-negative risk:  675 735 1148 1063 390 381 93 89 146 175 52 53 
New BC onsets:  114
BC status:  4886 114 
BC subtype:  4886 82 32 

clinical_engagement 
diagnosis 
demography 
76 new agents 
166 
disease_progression 
H-positive risk:  728 670 92 1075 372 93 1151 391 176 54 145 53 
H-negative risk:  670 728 1151 1075 391 372 93 92 145 176 53 54 
New BC onsets:  114
BC status:  4886 114 
BC subtype:  4886 82 32 

clinical_engagement 
diagnosis 
demography 
67 new agents 
167 
disease_progression 
H-positive risk:  719 673 94 1077 374 93 1155 393 172 53 143 54 
H-negative risk:  673 719 1155 1077 393 374 93 94 143 172 54 53 
New BC onsets:  114
BC status:  4886 114 
BC subtype:  4886 82 32 

clinical_engagement 
diagnosis 
demography 
78 new agents 
168 
disease_progression 
H-positive risk:  717 668 93 1082 372 92 1156 401 171 53 145 50 
H-negative risk:  668 717 1156 1082 401 372 92 93 145 171 50 53 
New BC onsets:  114
BC status:  4886 114 
BC subtype:  4886 83 31 

clinical_engagement 
diagnosis 
demography 
86 new agents 
169 
disease_progression 
H-positive risk:  718 669 93 1075 372 91 1161 397 171 57 143 53 
H-negative risk:  669 718 1161 1075 397 372 91 93 143 171 53 57 
New BC onsets:  117
BC status:  4883 117 
BC subtype:  4883 81 36 

clinical_engagement 
diagnosis 
demography 
74 new agents 
170 
disease_progression 
H-positive risk:  702 674 91 1081 378 89 1156 401 172 58 140 58 
H-negative risk:  674 702 1156 1081 401 378 89 91 140 172 58 58 
New BC onsets:  119
BC status:  4881 119 
BC subtype:  4881 83 36 

clinical_engagement 
diagnosis 
demography 
80 new agents 
171 
disease_progression 
H-positive risk:  705 673 96 1083 374 88 1155 399 169 59 140 59 
H-negative risk:  673 705 1155 1083 399 374 88 96 140 169 59 59 
New BC onsets:  120
BC status:  4880 120 
BC subtype:  4880 85 35 

clinical_engagement 
diagnosis 
demography 
81 new agents 
172 
disease_progression 
H-positive risk:  703 669 93 1097 377 86 1157 395 166 58 139 60 
H-negative risk:  669 703 1157 1097 395 377 86 93 139 166 60 58 
New BC onsets:  118
BC status:  4882 118 
BC subtype:  4882 84 34 

clinical_engagement 
diagnosis 
demography 
65 new agents 
173 
disease_progression 
H-positive risk:  705 668 93 1103 375 84 1154 396 172 57 135 58 
H-negative risk:  668 705 1154 1103 396 375 84 93 135 172 58 57 
New BC onsets:  117
BC status:  4883 117 
BC subtype:  4883 83 34 

clinical_engagement 
diagnosis 
demography 
64 new agents 
174 
disease_progression 
H-positive risk:  708 661 96 1106 376 84 1163 387 168 57 136 58 
H-negative risk:  661 708 1163 1106 387 376 84 96 136 168 58 57 
New BC onsets:  116
BC status:  4884 116 
BC subtype:  4884 83 33 

clinical_engagement 
diagnosis 
demography 
82 new agents 
175 
disease_progression 
H-positive risk:  709 657 95 1105 368 83 1168 393 167 59 137 59 
H-negative risk:  657 709 1168 1105 393 368 83 95 137 167 59 59 
New BC onsets:  115
BC status:  4885 115 
BC subtype:  4885 82 33 

clinical_engagement 
diagnosis 
demography 
73 new agents 
176 
disease_progression 
H-positive risk:  716 652 94 1112 371 83 1159 391 167 58 137 60 
H-negative risk:  652 716 1159 1112 391 371 83 94 137 167 60 58 
New BC onsets:  112
BC status:  4888 112 
BC subtype:  4888 83 29 

clinical_engagement 
diagnosis 
demography 
83 new agents 
177 
disease_progression 
H-positive risk:  722 646 97 1121 371 84 1156 383 166 58 136 60 
H-negative risk:  646 722 1156 1121 383 371 84 97 136 166 60 58 
New BC onsets:  112
BC status:  4888 112 
BC subtype:  4888 82 30 

clinical_engagement 
diagnosis 
demography 
72 new agents 
178 
disease_progression 
H-positive risk:  718 644 98 1118 370 85 1160 385 170 57 135 60 
H-negative risk:  644 718 1160 1118 385 370 85 98 135 170 60 57 
New BC onsets:  110
BC status:  4890 110 
BC subtype:  4890 78 32 

clinical_engagement 
diagnosis 
demography 
70 new agents 
179 
disease_progression 
H-positive risk:  711 645 99 1113 379 86 1159 389 170 56 134 59 
H-negative risk:  645 711 1159 1113 389 379 86 99 134 170 59 56 
New BC onsets:  114
BC status:  4886 114 
BC subtype:  4886 81 33 

clinical_engagement 
diagnosis 
demography 
71 new agents 
180 
disease_progression 
H-positive risk:  710 648 99 1108 380 86 1161 393 169 55 132 59 
H-negative risk:  648 710 1161 1108 393 380 86 99 132 169 59 55 
New BC onsets:  112
BC status:  4888 112 
BC subtype:  4888 81 31 

clinical_engagement 
diagnosis 
demography 
73 new agents 
181 
disease_progression 
H-positive risk:  706 645 97 1114 382 84 1164 391 171 55 133 58 
H-negative risk:  645 706 1164 1114 391 382 84 97 133 171 58 55 
New BC onsets:  111
BC status:  4889 111 
BC subtype:  4889 80 31 

clinical_engagement 
diagnosis 
demography 
99 new agents 
182 
disease_progression 
H-positive risk:  710 655 97 1101 395 81 1147 393 171 58 133 59 
H-negative risk:  655 710 1147 1101 393 395 81 97 133 171 59 58 
New BC onsets:  111
BC status:  4889 111 
BC subtype:  4889 79 32 

clinical_engagement 
diagnosis 
demography 
75 new agents 
183 
disease_progression 
H-positive risk:  711 651 98 1108 400 82 1142 393 174 54 133 54 
H-negative risk:  651 711 1142 1108 393 400 82 98 133 174 54 54 
New BC onsets:  113
BC status:  4887 113 
BC subtype:  4887 79 34 

clinical_engagement 
diagnosis 
demography 
77 new agents 
184 
disease_progression 
H-positive risk:  701 654 95 1104 395 83 1164 388 172 53 135 56 
H-negative risk:  654 701 1164 1104 388 395 83 95 135 172 56 53 
New BC onsets:  116
BC status:  4884 116 
BC subtype:  4884 82 34 

clinical_engagement 
diagnosis 
demography 
84 new agents 
185 
disease_progression 
H-positive risk:  699 666 95 1101 394 86 1149 391 174 51 137 57 
H-negative risk:  666 699 1149 1101 391 394 86 95 137 174 57 51 
New BC onsets:  116
BC status:  4884 116 
BC subtype:  4884 82 34 

clinical_engagement 
diagnosis 
demography 
65 new agents 
186 
disease_progression 
H-positive risk:  699 668 96 1103 392 87 1140 400 169 53 137 56 
H-negative risk:  668 699 1140 1103 400 392 87 96 137 169 56 53 
New BC onsets:  114
BC status:  4886 114 
BC subtype:  4886 82 32 

clinical_engagement 
diagnosis 
demography 
78 new agents 
187 
disease_progression 
H-positive risk:  700 662 98 1108 394 86 1148 394 165 51 137 57 
H-negative risk:  662 700 1148 1108 394 394 86 98 137 165 57 51 
New BC onsets:  112
BC status:  4888 112 
BC subtype:  4888 82 30 

clinical_engagement 
diagnosis 
demography 
58 new agents 
188 
disease_progression 
H-positive risk:  692 665 99 1104 400 87 1156 389 165 50 138 55 
H-negative risk:  665 692 1156 1104 389 400 87 99 138 165 55 50 
New BC onsets:  113
BC status:  4887 113 
BC subtype:  4887 83 30 

clinical_engagement 
diagnosis 
demography 
81 new agents 
189 
disease_progression 
H-positive risk:  689 673 98 1102 400 87 1155 389 164 51 136 56 
H-negative risk:  673 689 1155 1102 389 400 87 98 136 164 56 51 
New BC onsets:  112
BC status:  4888 112 
BC subtype:  4888 83 29 

clinical_engagement 
diagnosis 
demography 
93 new agents 
190 
disease_progression 
H-positive risk:  688 679 100 1104 396 88 1145 389 163 53 139 56 
H-negative risk:  679 688 1145 1104 389 396 88 100 139 163 56 53 
New BC onsets:  110
BC status:  4890 110 
BC subtype:  4890 81 29 

clinical_engagement 
diagnosis 
demography 
72 new agents 
191 
disease_progression 
H-positive risk:  692 677 98 1103 397 86 1149 387 165 51 139 56 
H-negative risk:  677 692 1149 1103 387 397 86 98 139 165 56 51 
New BC onsets:  108
BC status:  4892 108 
BC subtype:  4892 79 29 

clinical_engagement 
diagnosis 
demography 
78 new agents 
192 
disease_progression 
H-positive risk:  691 676 98 1103 399 86 1151 380 165 54 139 58 
H-negative risk:  676 691 1151 1103 380 399 86 98 139 165 58 54 
New BC onsets:  106
BC status:  4894 106 
BC subtype:  4894 77 29 

clinical_engagement 
diagnosis 
demography 
75 new agents 
193 
disease_progression 
H-positive risk:  692 671 98 1110 404 87 1144 380 163 55 140 56 
H-negative risk:  671 692 1144 1110 380 404 87 98 140 163 56 55 
New BC onsets:  105
BC status:  4895 105 
BC subtype:  4895 76 29 

clinical_engagement 
diagnosis 
demography 
80 new agents 
194 
disease_progression 
H-positive risk:  690 661 96 1111 414 88 1146 384 162 52 142 54 
H-negative risk:  661 690 1146 1111 384 414 88 96 142 162 54 52 
New BC onsets:  104
BC status:  4896 104 
BC subtype:  4896 75 29 

clinical_engagement 
diagnosis 
demography 
74 new agents 
195 
disease_progression 
H-positive risk:  694 661 99 1103 417 88 1140 389 159 51 139 60 
H-negative risk:  661 694 1140 1103 389 417 88 99 139 159 60 51 
New BC onsets:  105
BC status:  4895 105 
BC subtype:  4895 74 31 

clinical_engagement 
diagnosis 
demography 
83 new agents 
196 
disease_progression 
H-positive risk:  696 660 97 1104 415 88 1148 385 157 51 140 59 
H-negative risk:  660 696 1148 1104 385 415 88 97 140 157 59 51 
New BC onsets:  105
BC status:  4895 105 
BC subtype:  4895 73 32 

clinical_engagement 
diagnosis 
demography 
59 new agents 
197 
disease_progression 
H-positive risk:  700 661 96 1098 416 89 1146 390 156 52 137 59 
H-negative risk:  661 700 1146 1098 390 416 89 96 137 156 59 52 
New BC onsets:  100
BC status:  4900 100 
BC subtype:  4900 68 32 

clinical_engagement 
diagnosis 
demography 
81 new agents 
198 
disease_progression 
H-positive risk:  706 664 96 1083 421 89 1146 389 158 53 137 58 
H-negative risk:  664 706 1146 1083 389 421 89 96 137 158 58 53 
New BC onsets:  104
BC status:  4896 104 
BC subtype:  4896 71 33 

clinical_engagement 
diagnosis 
demography 
76 new agents 
199 
disease_progression 
H-positive risk:  709 662 92 1086 415 86 1151 390 161 52 141 55 
H-negative risk:  662 709 1151 1086 390 415 86 92 141 161 55 52 
New BC onsets:  103
BC status:  4897 103 
BC subtype:  4897 70 33 

clinical_engagement 
diagnosis 
demography 
60 new agents 
200 
disease_progression 
H-positive risk:  708 667 93 1073 417 83 1152 392 167 53 139 56 
H-negative risk:  667 708 1152 1073 392 417 83 93 139 167 56 53 
New BC onsets:  101
BC status:  4899 101 
BC subtype:  4899 68 33 

clinical_engagement 
diagnosis 
demography 
88 new agents 
201 
disease_progression 
H-positive risk:  708 672 92 1078 410 85 1152 388 168 52 141 54 
H-negative risk:  672 708 1152 1078 388 410 85 92 141 168 54 52 
New BC onsets:  102
BC status:  4898 102 
BC subtype:  4898 67 35 

clinical_engagement 
diagnosis 
demography 
71 new agents 
202 
disease_progression 
H-positive risk:  711 667 91 1083 415 83 1146 386 171 49 143 55 
H-negative risk:  667 711 1146 1083 386 415 83 91 143 171 55 49 
New BC onsets:  104
BC status:  4896 104 
BC subtype:  4896 69 35 

clinical_engagement 
diagnosis 
demography 
67 new agents 
203 
disease_progression 
H-positive risk:  710 668 93 1076 418 82 1143 385 179 51 142 53 
H-negative risk:  668 710 1143 1076 385 418 82 93 142 179 53 51 
New BC onsets:  104
BC status:  4896 104 
BC subtype:  4896 70 34 

clinical_engagement 
diagnosis 
demography 
80 new agents 
204 
disease_progression 
H-positive risk:  716 673 92 1078 412 85 1140 383 177 51 140 53 
H-negative risk:  673 716 1140 1078 383 412 85 92 140 177 53 51 
New BC onsets:  108
BC status:  4892 108 
BC subtype:  4892 73 35 

clinical_engagement 
diagnosis 
demography 
61 new agents 
205 
disease_progression 
H-positive risk:  712 673 92 1095 403 85 1142 380 177 50 139 52 
H-negative risk:  673 712 1142 1095 380 403 85 92 139 177 52 50 
New BC onsets:  106
BC status:  4894 106 
BC subtype:  4894 72 34 

clinical_engagement 
diagnosis 
demography 
89 new agents 
206 
disease_progression 
H-positive risk:  709 665 90 1099 405 83 1133 394 179 49 139 55 
H-negative risk:  665 709 1133 1099 394 405 83 90 139 179 55 49 
New BC onsets:  108
BC status:  4892 108 
BC subtype:  4892 74 34 

clinical_engagement 
diagnosis 
demography 
78 new agents 
207 
disease_progression 
H-positive risk:  709 663 90 1106 403 81 1140 391 176 47 137 57 
H-negative risk:  663 709 1140 1106 391 403 81 90 137 176 57 47 
New BC onsets:  110
BC status:  4890 110 
BC subtype:  4890 77 33 

clinical_engagement 
diagnosis 
demography 
77 new agents 
208 
disease_progression 
H-positive risk:  702 661 88 1115 395 84 1140 400 173 48 137 57 
H-negative risk:  661 702 1140 1115 400 395 84 88 137 173 57 48 
New BC onsets:  110
BC status:  4890 110 
BC subtype:  4890 78 32 

clinical_engagement 
diagnosis 
demography 
71 new agents 
209 
disease_progression 
H-positive risk:  705 659 87 1113 390 83 1141 409 175 48 134 56 
H-negative risk:  659 705 1141 1113 409 390 83 87 134 175 56 48 
New BC onsets:  110
BC status:  4890 110 
BC subtype:  4890 78 32 

clinical_engagement 
diagnosis 
demography 
75 new agents 
210 
disease_progression 
H-positive risk:  704 660 89 1117 388 79 1143 412 173 47 131 57 
H-negative risk:  660 704 1143 1117 412 388 79 89 131 173 57 47 
New BC onsets:  111
BC status:  4889 111 
BC subtype:  4889 79 32 

clinical_engagement 
diagnosis 
demography 
76 new agents 
211 
disease_progression 
H-positive risk:  703 666 88 1110 388 80 1145 412 173 47 132 56 
H-negative risk:  666 703 1145 1110 412 388 80 88 132 173 56 47 
New BC onsets:  112
BC status:  4888 112 
BC subtype:  4888 80 32 

clinical_engagement 
diagnosis 
demography 
75 new agents 
212 
disease_progression 
H-positive risk:  711 663 89 1113 386 78 1145 407 176 47 130 55 
H-negative risk:  663 711 1145 1113 407 386 78 89 130 176 55 47 
New BC onsets:  113
BC status:  4887 113 
BC subtype:  4887 81 32 

clinical_engagement 
diagnosis 
demography 
86 new agents 
213 
disease_progression 
H-positive risk:  711 666 90 1114 381 78 1145 402 180 48 128 57 
H-negative risk:  666 711 1145 1114 402 381 78 90 128 180 57 48 
New BC onsets:  116
BC status:  4884 116 
BC subtype:  4884 83 33 

clinical_engagement 
diagnosis 
demography 
63 new agents 
214 
disease_progression 
H-positive risk:  710 657 88 1124 383 80 1140 404 178 48 131 57 
H-negative risk:  657 710 1140 1124 404 383 80 88 131 178 57 48 
New BC onsets:  118
BC status:  4882 118 
BC subtype:  4882 86 32 

clinical_engagement 
diagnosis 
demography 
86 new agents 
215 
disease_progression 
H-positive risk:  702 656 92 1130 380 79 1148 397 177 51 128 60 
H-negative risk:  656 702 1148 1130 397 380 79 92 128 177 60 51 
New BC onsets:  120
BC status:  4880 120 
BC subtype:  4880 89 31 

clinical_engagement 
diagnosis 
demography 
90 new agents 
216 
disease_progression 
H-positive risk:  700 659 93 1131 377 83 1155 390 173 52 128 59 
H-negative risk:  659 700 1155 1131 390 377 83 93 128 173 59 52 
New BC onsets:  121
BC status:  4879 121 
BC subtype:  4879 89 32 

clinical_engagement 
diagnosis 
demography 
65 new agents 
217 
disease_progression 
H-positive risk:  703 664 93 1110 391 83 1142 400 172 55 127 60 
H-negative risk:  664 703 1142 1110 400 391 83 93 127 172 60 55 
New BC onsets:  120
BC status:  4880 120 
BC subtype:  4880 88 32 

clinical_engagement 
diagnosis 
demography 
92 new agents 
218 
disease_progression 
H-positive risk:  709 666 96 1106 384 83 1148 392 172 56 125 63 
H-negative risk:  666 709 1148 1106 392 384 83 96 125 172 63 56 
New BC onsets:  124
BC status:  4876 124 
BC subtype:  4876 92 32 

clinical_engagement 
diagnosis 
demography 
90 new agents 
219 
disease_progression 
H-positive risk:  708 672 97 1108 389 85 1142 384 171 56 126 62 
H-negative risk:  672 708 1142 1108 384 389 85 97 126 171 62 56 
New BC onsets:  124
BC status:  4876 124 
BC subtype:  4876 93 31 

clinical_engagement 
diagnosis 
demography 
88 new agents 
220 
disease_progression 
H-positive risk:  703 677 98 1106 382 87 1146 385 169 56 129 62 
H-negative risk:  677 703 1146 1106 385 382 87 98 129 169 62 56 
New BC onsets:  123
BC status:  4877 123 
BC subtype:  4877 91 32 

clinical_engagement 
diagnosis 
demography 
84 new agents 
221 
disease_progression 
H-positive risk:  697 680 98 1104 386 86 1160 375 172 53 128 61 
H-negative risk:  680 697 1160 1104 375 386 86 98 128 172 61 53 
New BC onsets:  123
BC status:  4877 123 
BC subtype:  4877 90 33 

clinical_engagement 
diagnosis 
demography 
71 new agents 
222 
disease_progression 
H-positive risk:  697 687 98 1095 383 87 1166 371 173 54 129 60 
H-negative risk:  687 697 1166 1095 371 383 87 98 129 173 60 54 
New BC onsets:  120
BC status:  4880 120 
BC subtype:  4880 89 31 

clinical_engagement 
diagnosis 
demography 
72 new agents 
223 
disease_progression 
H-positive risk:  691 679 98 1091 391 88 1175 373 174 53 129 58 
H-negative risk:  679 691 1175 1091 373 391 88 98 129 174 58 53 
New BC onsets:  120
BC status:  4880 120 
BC subtype:  4880 89 31 

clinical_engagement 
diagnosis 
demography 
85 new agents 
224 
disease_progression 
H-positive risk:  691 683 96 1091 403 85 1161 379 172 54 129 56 
H-negative risk:  683 691 1161 1091 379 403 85 96 129 172 56 54 
New BC onsets:  116
BC status:  4884 116 
BC subtype:  4884 86 30 

clinical_engagement 
diagnosis 
demography 
75 new agents 
225 
disease_progression 
H-positive risk:  690 688 95 1094 396 85 1157 384 172 53 134 52 
H-negative risk:  688 690 1157 1094 384 396 85 95 134 172 52 53 
New BC onsets:  118
BC status:  4882 118 
BC subtype:  4882 84 34 

clinical_engagement 
diagnosis 
demography 
61 new agents 
226 
disease_progression 
H-positive risk:  686 684 96 1099 403 83 1158 380 172 53 137 49 
H-negative risk:  684 686 1158 1099 380 403 83 96 137 172 49 53 
New BC onsets:  115
BC status:  4885 115 
BC subtype:  4885 83 32 

clinical_engagement 
diagnosis 
demography 
63 new agents 
227 
disease_progression 
H-positive risk:  685 680 95 1098 403 82 1158 382 177 50 140 50 
H-negative risk:  680 685 1158 1098 382 403 82 95 140 177 50 50 
New BC onsets:  113
BC status:  4887 113 
BC subtype:  4887 81 32 

clinical_engagement 
diagnosis 
demography 
70 new agents 
228 
disease_progression 
H-positive risk:  687 676 95 1095 407 80 1158 384 175 50 143 50 
H-negative risk:  676 687 1158 1095 384 407 80 95 143 175 50 50 
New BC onsets:  114
BC status:  4886 114 
BC subtype:  4886 80 34 

clinical_engagement 
diagnosis 
demography 
75 new agents 
229 
disease_progression 
H-positive risk:  683 676 96 1082 418 80 1148 399 173 55 141 49 
H-negative risk:  676 683 1148 1082 399 418 80 96 141 173 49 55 
New BC onsets:  114
BC status:  4886 114 
BC subtype:  4886 80 34 

clinical_engagement 
diagnosis 
demography 
69 new agents 
230 
disease_progression 
H-positive risk:  678 675 96 1084 427 78 1150 393 174 55 140 50 
H-negative risk:  675 678 1150 1084 393 427 78 96 140 174 50 55 
New BC onsets:  118
BC status:  4882 118 
BC subtype:  4882 82 36 

clinical_engagement 
diagnosis 
demography 
83 new agents 
231 
disease_progression 
H-positive risk:  675 680 96 1079 423 78 1141 401 179 55 147 46 
H-negative risk:  680 675 1141 1079 401 423 78 96 147 179 46 55 
New BC onsets:  115
BC status:  4885 115 
BC subtype:  4885 82 33 

clinical_engagement 
diagnosis 
demography 
61 new agents 
232 
disease_progression 
H-positive risk:  677 683 95 1073 423 77 1136 401 183 59 147 46 
H-negative risk:  683 677 1136 1073 401 423 77 95 147 183 46 59 
New BC onsets:  121
BC status:  4879 121 
BC subtype:  4879 85 36 

clinical_engagement 
diagnosis 
demography 
83 new agents 
233 
disease_progression 
H-positive risk:  678 675 94 1076 423 80 1137 404 184 58 146 45 
H-negative risk:  675 678 1137 1076 404 423 80 94 146 184 45 58 
New BC onsets:  119
BC status:  4881 119 
BC subtype:  4881 85 34 

clinical_engagement 
diagnosis 
demography 
92 new agents 
234 
disease_progression 
H-positive risk:  670 683 98 1079 418 80 1151 393 179 60 144 45 
H-negative risk:  683 670 1151 1079 393 418 80 98 144 179 45 60 
New BC onsets:  116
BC status:  4884 116 
BC subtype:  4884 82 34 

clinical_engagement 
diagnosis 
demography 
73 new agents 
235 
disease_progression 
H-positive risk:  680 686 98 1082 410 81 1143 389 179 61 146 45 
H-negative risk:  686 680 1143 1082 389 410 81 98 146 179 45 61 
New BC onsets:  116
BC status:  4884 116 
BC subtype:  4884 82 34 

clinical_engagement 
diagnosis 
demography 
83 new agents 
236 
disease_progression 
H-positive risk:  672 682 104 1090 408 82 1152 384 176 62 146 42 
H-negative risk:  682 672 1152 1090 384 408 82 104 146 176 42 62 
New BC onsets:  117
BC status:  4883 117 
BC subtype:  4883 82 35 

clinical_engagement 
diagnosis 
demography 
86 new agents 
237 
disease_progression 
H-positive risk:  677 673 107 1091 412 82 1151 388 173 58 149 39 
H-negative risk:  673 677 1151 1091 388 412 82 107 149 173 39 58 
New BC onsets:  118
BC status:  4882 118 
BC subtype:  4882 83 35 

clinical_engagement 
diagnosis 
demography 
84 new agents 
238 
disease_progression 
H-positive risk:  676 674 102 1083 413 85 1156 387 174 58 153 39 
H-negative risk:  674 676 1156 1083 387 413 85 102 153 174 39 58 
New BC onsets:  118
BC status:  4882 118 
BC subtype:  4882 83 35 

clinical_engagement 
diagnosis 
demography 
82 new agents 
239 
disease_progression 
H-positive risk:  690 679 101 1080 405 86 1156 384 169 58 153 39 
H-negative risk:  679 690 1156 1080 384 405 86 101 153 169 39 58 
New BC onsets:  118
BC status:  4882 118 
BC subtype:  4882 83 35 

clinical_engagement 
diagnosis 
demography 
68 new agents 
240 
disease_progression 
H-positive risk:  689 682 101 1072 407 86 1159 386 168 58 154 38 
H-negative risk:  682 689 1159 1072 386 407 86 101 154 168 38 58 
New BC onsets:  116
BC status:  4884 116 
BC subtype:  4884 81 35 

clinical_engagement 
diagnosis 
demography 
76 new agents 
241 
disease_progression 
H-positive risk:  681 688 103 1060 418 87 1155 397 163 60 151 37 
H-negative risk:  688 681 1155 1060 397 418 87 103 151 163 37 60 
New BC onsets:  115
BC status:  4885 115 
BC subtype:  4885 79 36 

clinical_engagement 
diagnosis 
demography 
77 new agents 
242 
disease_progression 
H-positive risk:  677 681 105 1061 419 86 1154 400 163 61 152 41 
H-negative risk:  681 677 1154 1061 400 419 86 105 152 163 41 61 
New BC onsets:  119
BC status:  4881 119 
BC subtype:  4881 83 36 

clinical_engagement 
diagnosis 
demography 
72 new agents 
243 
disease_progression 
H-positive risk:  682 676 105 1071 409 87 1147 407 163 60 154 39 
H-negative risk:  676 682 1147 1071 407 409 87 105 154 163 39 60 
New BC onsets:  116
BC status:  4884 116 
BC subtype:  4884 82 34 

clinical_engagement 
diagnosis 
demography 
81 new agents 
244 
disease_progression 
H-positive risk:  681 680 106 1078 401 87 1148 406 160 61 155 37 
H-negative risk:  680 681 1148 1078 406 401 87 106 155 160 37 61 
New BC onsets:  116
BC status:  4884 116 
BC subtype:  4884 82 34 

clinical_engagement 
diagnosis 
demography 
80 new agents 
245 
disease_progression 
H-positive risk:  681 680 104 1075 401 85 1149 400 166 61 159 39 
H-negative risk:  680 681 1149 1075 400 401 85 104 159 166 39 61 
New BC onsets:  114
BC status:  4886 114 
BC subtype:  4886 80 34 

clinical_engagement 
diagnosis 
demography 
75 new agents 
246 
disease_progression 
H-positive risk:  676 688 102 1066 406 85 1137 415 165 62 160 38 
H-negative risk:  688 676 1137 1066 415 406 85 102 160 165 38 62 
New BC onsets:  117
BC status:  4883 117 
BC subtype:  4883 82 35 

clinical_engagement 
diagnosis 
demography 
82 new agents 
247 
disease_progression 
H-positive risk:  683 690 105 1069 402 87 1128 412 161 64 162 37 
H-negative risk:  690 683 1128 1069 412 402 87 105 162 161 37 64 
New BC onsets:  119
BC status:  4881 119 
BC subtype:  4881 84 35 

clinical_engagement 
diagnosis 
demography 
66 new agents 
248 
disease_progression 
H-positive risk:  683 690 105 1072 401 89 1122 412 157 68 161 40 
H-negative risk:  690 683 1122 1072 412 401 89 105 161 157 40 68 
New BC onsets:  116
BC status:  4884 116 
BC subtype:  4884 81 35 

clinical_engagement 
diagnosis 
demography 
98 new agents 
249 
disease_progression 
H-positive risk:  676 697 104 1071 399 89 1127 415 156 67 157 42 
H-negative risk:  697 676 1127 1071 415 399 89 104 157 156 42 67 
New BC onsets:  114
BC status:  4886 114 
BC subtype:  4886 79 35 

clinical_engagement 
diagnosis 
demography 
71 new agents 
250 
disease_progression 
H-positive risk:  678 703 107 1067 400 87 1128 411 157 67 152 43 
H-negative risk:  703 678 1128 1067 411 400 87 107 152 157 43 67 
New BC onsets:  115
BC status:  4885 115 
BC subtype:  4885 80 35 

clinical_engagement 
diagnosis 
demography 
74 new agents 
251 
disease_progression 
H-positive risk:  678 708 109 1059 398 88 1124 415 155 70 149 47 
H-negative risk:  708 678 1124 1059 415 398 88 109 149 155 47 70 
New BC onsets:  113
BC status:  4887 113 
BC subtype:  4887 78 35 

clinical_engagement 
diagnosis 
demography 
75 new agents 
252 
disease_progression 
H-positive risk:  674 711 108 1060 397 90 1122 415 154 71 149 49 
H-negative risk:  711 674 1122 1060 415 397 90 108 149 154 49 71 
New BC onsets:  113
BC status:  4887 113 
BC subtype:  4887 78 35 

clinical_engagement 
diagnosis 
demography 
76 new agents 
253 
disease_progression 
H-positive risk:  682 711 111 1050 407 92 1108 416 155 68 151 49 
H-negative risk:  711 682 1108 1050 416 407 92 111 151 155 49 68 
New BC onsets:  114
BC status:  4886 114 
BC subtype:  4886 81 33 

clinical_engagement 
diagnosis 
demography 
88 new agents 
254 
disease_progression 
H-positive risk:  688 717 108 1046 398 92 1104 421 154 69 158 45 
H-negative risk:  717 688 1104 1046 421 398 92 108 158 154 45 69 
New BC onsets:  110
BC status:  4890 110 
BC subtype:  4890 77 33 

clinical_engagement 
diagnosis 
demography 
81 new agents 
255 
disease_progression 
H-positive risk:  688 713 108 1066 384 91 1105 420 155 67 159 44 
H-negative risk:  713 688 1105 1066 420 384 91 108 159 155 44 67 
New BC onsets:  109
BC status:  4891 109 
BC subtype:  4891 78 31 

clinical_engagement 
diagnosis 
demography 
77 new agents 
256 
disease_progression 
H-positive risk:  695 704 107 1073 383 93 1095 429 152 66 158 45 
H-negative risk:  704 695 1095 1073 429 383 93 107 158 152 45 66 
New BC onsets:  107
BC status:  4893 107 
BC subtype:  4893 78 29 

clinical_engagement 
diagnosis 
demography 
74 new agents 
257 
disease_progression 
H-positive risk:  690 703 108 1073 389 94 1096 427 151 66 159 44 
H-negative risk:  703 690 1096 1073 427 389 94 108 159 151 44 66 
New BC onsets:  105
BC status:  4895 105 
BC subtype:  4895 77 28 

clinical_engagement 
diagnosis 
demography 
82 new agents 
258 
disease_progression 
H-positive risk:  689 701 108 1077 382 94 1103 429 144 69 159 45 
H-negative risk:  701 689 1103 1077 429 382 94 108 159 144 45 69 
New BC onsets:  105
BC status:  4895 105 
BC subtype:  4895 76 29 

clinical_engagement 
diagnosis 
demography 
70 new agents 
259 
disease_progression 
H-positive risk:  686 698 109 1078 388 96 1102 427 139 71 161 45 
H-negative risk:  698 686 1102 1078 427 388 96 109 161 139 45 71 
New BC onsets:  106
BC status:  4894 106 
BC subtype:  4894 78 28 

clinical_engagement 
diagnosis 
demography 
79 new agents 
260 
disease_progression 
H-positive risk:  689 706 109 1074 381 98 1104 418 141 70 164 46 
H-negative risk:  706 689 1104 1074 418 381 98 109 164 141 46 70 
New BC onsets:  106
BC status:  4894 106 
BC subtype:  4894 78 28 

clinical_engagement 
diagnosis 
demography 
75 new agents 
261 
disease_progression 
H-positive risk:  674 713 108 1082 379 99 1108 415 142 72 163 45 
H-negative risk:  713 674 1108 1082 415 379 99 108 163 142 45 72 
New BC onsets:  103
BC status:  4897 103 
BC subtype:  4897 77 26 

clinical_engagement 
diagnosis 
demography 
69 new agents 
262 
disease_progression 
H-positive risk:  680 722 108 1072 389 100 1104 411 142 71 158 43 
H-negative risk:  722 680 1104 1072 411 389 100 108 158 142 43 71 
New BC onsets:  102
BC status:  4898 102 
BC subtype:  4898 76 26 

clinical_engagement 
diagnosis 
demography 
68 new agents 
263 
disease_progression 
H-positive risk:  681 721 106 1065 397 99 1103 409 142 71 164 42 
H-negative risk:  721 681 1103 1065 409 397 99 106 164 142 42 71 
New BC onsets:  104
BC status:  4896 104 
BC subtype:  4896 74 30 

clinical_engagement 
diagnosis 
demography 
74 new agents 
264 
disease_progression 
H-positive risk:  682 720 105 1060 389 102 1102 420 138 75 164 43 
H-negative risk:  720 682 1102 1060 420 389 102 105 164 138 43 75 
New BC onsets:  104
BC status:  4896 104 
BC subtype:  4896 74 30 

clinical_engagement 
diagnosis 
demography 
68 new agents 
265 
disease_progression 
H-positive risk:  679 722 107 1061 386 100 1097 423 142 76 161 46 
H-negative risk:  722 679 1097 1061 423 386 100 107 161 142 46 76 
New BC onsets:  101
BC status:  4899 101 
BC subtype:  4899 74 27 

clinical_engagement 
diagnosis 
demography 
89 new agents 
266 
disease_progression 
H-positive risk:  683 731 109 1061 377 99 1100 418 142 73 160 47 
H-negative risk:  731 683 1100 1061 418 377 99 109 160 142 47 73 
New BC onsets:  102
BC status:  4898 102 
BC subtype:  4898 74 28 

clinical_engagement 
diagnosis 
demography 
64 new agents 
267 
disease_progression 
H-positive risk:  681 727 106 1074 385 100 1088 417 140 75 159 48 
H-negative risk:  727 681 1088 1074 417 385 100 106 159 140 48 75 
New BC onsets:  103
BC status:  4897 103 
BC subtype:  4897 75 28 

clinical_engagement 
diagnosis 
demography 
87 new agents 
268 
disease_progression 
H-positive risk:  685 727 105 1076 389 98 1081 420 142 72 155 50 
H-negative risk:  727 685 1081 1076 420 389 98 105 155 142 50 72 
New BC onsets:  101
BC status:  4899 101 
BC subtype:  4899 76 25 

clinical_engagement 
diagnosis 
demography 
73 new agents 
269 
disease_progression 
H-positive risk:  683 727 104 1071 389 98 1080 424 146 73 153 52 
H-negative risk:  727 683 1080 1071 424 389 98 104 153 146 52 73 
New BC onsets:  99
BC status:  4901 99 
BC subtype:  4901 74 25 

clinical_engagement 
diagnosis 
demography 
68 new agents 
270 
disease_progression 
H-positive risk:  686 730 105 1067 391 97 1082 423 146 70 153 50 
H-negative risk:  730 686 1082 1067 423 391 97 105 153 146 50 70 
New BC onsets:  99
BC status:  4901 99 
BC subtype:  4901 73 26 

clinical_engagement 
diagnosis 
demography 
100 new agents 
271 
disease_progression 
H-positive risk:  681 739 104 1060 388 98 1088 421 153 65 154 49 
H-negative risk:  739 681 1088 1060 421 388 98 104 154 153 49 65 
New BC onsets:  101
BC status:  4899 101 
BC subtype:  4899 76 25 

clinical_engagement 
diagnosis 
demography 
66 new agents 
272 
disease_progression 
H-positive risk:  674 735 105 1056 387 98 1098 419 154 64 156 54 
H-negative risk:  735 674 1098 1056 419 387 98 105 156 154 54 64 
New BC onsets:  103
BC status:  4897 103 
BC subtype:  4897 77 26 

clinical_engagement 
diagnosis 
demography 
70 new agents 
273 
disease_progression 
H-positive risk:  671 733 103 1058 385 98 1098 427 154 62 156 55 
H-negative risk:  733 671 1098 1058 427 385 98 103 156 154 55 62 
New BC onsets:  105
BC status:  4895 105 
BC subtype:  4895 79 26 

clinical_engagement 
diagnosis 
demography 
71 new agents 
274 
disease_progression 
H-positive risk:  674 723 106 1054 380 100 1101 431 156 61 156 58 
H-negative risk:  723 674 1101 1054 431 380 100 106 156 156 58 61 
New BC onsets:  102
BC status:  4898 102 
BC subtype:  4898 77 25 

clinical_engagement 
diagnosis 
demography 
62 new agents 
275 
disease_progression 
H-positive risk:  673 725 103 1050 379 99 1106 433 157 60 158 57 
H-negative risk:  725 673 1106 1050 433 379 99 103 158 157 57 60 
New BC onsets:  104
BC status:  4896 104 
BC subtype:  4896 80 24 

clinical_engagement 
diagnosis 
demography 
76 new agents 
276 
disease_progression 
H-positive risk:  675 737 105 1044 381 102 1100 429 155 60 156 56 
H-negative risk:  737 675 1100 1044 429 381 102 105 156 155 56 60 
New BC onsets:  104
BC status:  4896 104 
BC subtype:  4896 79 25 

clinical_engagement 
diagnosis 
demography 
73 new agents 
277 
disease_progression 
H-positive risk:  677 736 106 1037 384 102 1097 431 157 60 154 59 
H-negative risk:  736 677 1097 1037 431 384 102 106 154 157 59 60 
New BC onsets:  109
BC status:  4891 109 
BC subtype:  4891 84 25 

clinical_engagement 
diagnosis 
demography 
64 new agents 
278 
disease_progression 
H-positive risk:  668 739 104 1040 382 102 1106 431 157 60 152 59 
H-negative risk:  739 668 1106 1040 431 382 102 104 152 157 59 60 
New BC onsets:  111
BC status:  4889 111 
BC subtype:  4889 86 25 

clinical_engagement 
diagnosis 
demography 
72 new agents 
279 
disease_progression 
H-positive risk:  664 736 102 1043 387 104 1103 430 159 58 156 58 
H-negative risk:  736 664 1103 1043 430 387 104 102 156 159 58 58 
New BC onsets:  110
BC status:  4890 110 
BC subtype:  4890 83 27 

clinical_engagement 
diagnosis 
demography 
80 new agents 
280 
disease_progression 
H-positive risk:  670 741 102 1046 385 103 1102 421 158 60 151 61 
H-negative risk:  741 670 1102 1046 421 385 103 102 151 158 61 60 
New BC onsets:  111
BC status:  4889 111 
BC subtype:  4889 80 31 

clinical_engagement 
diagnosis 
demography 
64 new agents 
281 
disease_progression 
H-positive risk:  671 733 102 1050 385 103 1094 429 161 58 152 62 
H-negative risk:  733 671 1094 1050 429 385 103 102 152 161 62 58 
New BC onsets:  108
BC status:  4892 108 
BC subtype:  4892 77 31 

clinical_engagement 
diagnosis 
demography 
71 new agents 
282 
disease_progression 
H-positive risk:  673 727 102 1055 387 103 1087 433 160 57 154 62 
H-negative risk:  727 673 1087 1055 433 387 103 102 154 160 62 57 
New BC onsets:  108
BC status:  4892 108 
BC subtype:  4892 77 31 

clinical_engagement 
diagnosis 
demography 
90 new agents 
283 
disease_progression 
H-positive risk:  671 733 100 1055 385 107 1089 424 157 58 157 64 
H-negative risk:  733 671 1089 1055 424 385 107 100 157 157 64 58 
New BC onsets:  108
BC status:  4892 108 
BC subtype:  4892 75 33 

clinical_engagement 
diagnosis 
demography 
76 new agents 
284 
disease_progression 
H-positive risk:  671 732 100 1059 389 106 1095 413 158 58 155 64 
H-negative risk:  732 671 1095 1059 413 389 106 100 155 158 64 58 
New BC onsets:  108
BC status:  4892 108 
BC subtype:  4892 75 33 

clinical_engagement 
diagnosis 
demography 
85 new agents 
285 
disease_progression 
H-positive risk:  668 733 100 1067 378 107 1098 408 158 63 156 64 
H-negative risk:  733 668 1098 1067 408 378 107 100 156 158 64 63 
New BC onsets:  106
BC status:  4894 106 
BC subtype:  4894 74 32 

clinical_engagement 
diagnosis 
demography 
74 new agents 
286 
disease_progression 
H-positive risk:  667 732 100 1065 367 106 1110 412 160 62 158 61 
H-negative risk:  732 667 1110 1065 412 367 106 100 158 160 61 62 
New BC onsets:  106
BC status:  4894 106 
BC subtype:  4894 73 33 

clinical_engagement 
diagnosis 
demography 
92 new agents 
287 
disease_progression 
H-positive risk:  664 730 102 1071 369 110 1104 406 163 62 158 61 
H-negative risk:  730 664 1104 1071 406 369 110 102 158 163 61 62 
New BC onsets:  105
BC status:  4895 105 
BC subtype:  4895 72 33 

clinical_engagement 
diagnosis 
demography 
64 new agents 
288 
disease_progression 
H-positive risk:  667 726 101 1073 371 110 1097 412 163 62 157 61 
H-negative risk:  726 667 1097 1073 412 371 110 101 157 163 61 62 
New BC onsets:  103
BC status:  4897 103 
BC subtype:  4897 70 33 

clinical_engagement 
diagnosis 
demography 
67 new agents 
289 
disease_progression 
H-positive risk:  673 722 101 1069 371 111 1101 410 165 62 155 60 
H-negative risk:  722 673 1101 1069 410 371 111 101 155 165 60 62 
New BC onsets:  101
BC status:  4899 101 
BC subtype:  4899 66 35 

clinical_engagement 
diagnosis 
demography 
74 new agents 
290 
disease_progression 
H-positive risk:  665 721 100 1072 372 114 1099 417 165 61 152 62 
H-negative risk:  721 665 1099 1072 417 372 114 100 152 165 62 61 
New BC onsets:  101
BC status:  4899 101 
BC subtype:  4899 66 35 

clinical_engagement 
diagnosis 
demography 
71 new agents 
291 
disease_progression 
H-positive risk:  660 714 98 1080 379 111 1090 428 166 62 149 63 
H-negative risk:  714 660 1090 1080 428 379 111 98 149 166 63 62 
New BC onsets:  101
BC status:  4899 101 
BC subtype:  4899 67 34 

clinical_engagement 
diagnosis 
demography 
74 new agents 
292 
disease_progression 
H-positive risk:  657 712 100 1080 380 111 1086 436 165 61 151 61 
H-negative risk:  712 657 1086 1080 436 380 111 100 151 165 61 61 
New BC onsets:  102
BC status:  4898 102 
BC subtype:  4898 69 33 

clinical_engagement 
diagnosis 
demography 
77 new agents 
293 
disease_progression 
H-positive risk:  662 713 99 1089 373 107 1081 441 163 62 149 61 
H-negative risk:  713 662 1081 1089 441 373 107 99 149 163 61 62 
New BC onsets:  103
BC status:  4897 103 
BC subtype:  4897 70 33 

clinical_engagement 
diagnosis 
demography 
81 new agents 
294 
disease_progression 
H-positive risk:  663 710 99 1085 377 109 1082 439 160 65 152 59 
H-negative risk:  710 663 1082 1085 439 377 109 99 152 160 59 65 
New BC onsets:  101
BC status:  4899 101 
BC subtype:  4899 68 33 

clinical_engagement 
diagnosis 
demography 
72 new agents 
295 
disease_progression 
H-positive risk:  666 707 96 1086 385 104 1085 430 164 64 154 59 
H-negative risk:  707 666 1085 1086 430 385 104 96 154 164 59 64 
New BC onsets:  102
BC status:  4898 102 
BC subtype:  4898 70 32 

clinical_engagement 
diagnosis 
demography 
67 new agents 
296 
disease_progression 
H-positive risk:  667 710 96 1084 383 107 1084 429 167 62 156 55 
H-negative risk:  710 667 1084 1084 429 383 107 96 156 167 55 62 
New BC onsets:  100
BC status:  4900 100 
BC subtype:  4900 68 32 

clinical_engagement 
diagnosis 
demography 
83 new agents 
297 
disease_progression 
H-positive risk:  660 707 100 1076 379 110 1090 435 168 61 159 55 
H-negative risk:  707 660 1090 1076 435 379 110 100 159 168 55 61 
New BC onsets:  99
BC status:  4901 99 
BC subtype:  4901 69 30 

clinical_engagement 
diagnosis 
demography 
88 new agents 
298 
disease_progression 
H-positive risk:  663 701 101 1078 384 111 1091 427 169 61 157 57 
H-negative risk:  701 663 1091 1078 427 384 111 101 157 169 57 61 
New BC onsets:  99
BC status:  4901 99 
BC subtype:  4901 69 30 

clinical_engagement 
diagnosis 
demography 
87 new agents 
299 
disease_progression 
H-positive risk:  661 698 104 1098 383 110 1083 420 170 63 155 55 
H-negative risk:  698 661 1083 1098 420 383 110 104 155 170 55 63 
New BC onsets:  101
BC status:  4899 101 
BC subtype:  4899 71 30 

clinical_engagement 
diagnosis 
demography 
92 new agents 
300 
disease_progression 
H-positive risk:  657 687 106 1108 379 107 1088 423 173 62 155 55 
H-negative risk:  687 657 1088 1108 423 379 107 106 155 173 55 62 
New BC onsets:  102
BC status:  4898 102 
BC subtype:  4898 72 30 

clinical_engagement 
diagnosis 
demography 
66 new agents 
301 
disease_progression 
H-positive risk:  653 693 107 1110 383 110 1081 417 172 64 153 57 
H-negative risk:  693 653 1081 1110 417 383 110 107 153 172 57 64 
New BC onsets:  102
BC status:  4898 102 
BC subtype:  4898 72 30 

clinical_engagement 
diagnosis 
demography 
79 new agents 
302 
disease_progression 
H-positive risk:  650 697 107 1111 384 108 1083 411 174 66 151 58 
H-negative risk:  697 650 1083 1111 411 384 108 107 151 174 58 66 
New BC onsets:  103
BC status:  4897 103 
BC subtype:  4897 72 31 

clinical_engagement 
diagnosis 
demography 
77 new agents 
303 
disease_progression 
H-positive risk:  654 692 112 1112 380 108 1080 410 177 65 149 61 
H-negative risk:  692 654 1080 1112 410 380 108 112 149 177 61 65 
New BC onsets:  102
BC status:  4898 102 
BC subtype:  4898 72 30 

clinical_engagement 
diagnosis 
demography 
74 new agents 
304 
disease_progression 
H-positive risk:  655 691 113 1116 386 110 1079 399 179 65 148 59 
H-negative risk:  691 655 1079 1116 399 386 110 113 148 179 59 65 
New BC onsets:  100
BC status:  4900 100 
BC subtype:  4900 70 30 

clinical_engagement 
diagnosis 
demography 
70 new agents 
305 
disease_progression 
H-positive risk:  657 683 114 1118 393 112 1069 402 181 66 146 59 
H-negative risk:  683 657 1069 1118 402 393 112 114 146 181 59 66 
New BC onsets:  100
BC status:  4900 100 
BC subtype:  4900 72 28 

clinical_engagement 
diagnosis 
demography 
79 new agents 
306 
disease_progression 
H-positive risk:  654 679 113 1120 391 111 1072 402 180 69 149 60 
H-negative risk:  679 654 1072 1120 402 391 111 113 149 180 60 69 
New BC onsets:  97
BC status:  4903 97 
BC subtype:  4903 70 27 

clinical_engagement 
diagnosis 
demography 
66 new agents 
307 
disease_progression 
H-positive risk:  654 675 109 1137 388 111 1069 399 183 65 149 61 
H-negative risk:  675 654 1069 1137 399 388 111 109 149 183 61 65 
New BC onsets:  99
BC status:  4901 99 
BC subtype:  4901 72 27 

clinical_engagement 
diagnosis 
demography 
73 new agents 
308 
disease_progression 
H-positive risk:  653 674 109 1135 390 108 1069 403 183 64 151 61 
H-negative risk:  674 653 1069 1135 403 390 108 109 151 183 61 64 
New BC onsets:  97
BC status:  4903 97 
BC subtype:  4903 70 27 

clinical_engagement 
diagnosis 
demography 
67 new agents 
309 
disease_progression 
H-positive risk:  655 667 106 1143 388 108 1063 412 180 67 153 58 
H-negative risk:  667 655 1063 1143 412 388 108 106 153 180 58 67 
New BC onsets:  100
BC status:  4900 100 
BC subtype:  4900 73 27 

clinical_engagement 
diagnosis 
demography 
77 new agents 
310 
disease_progression 
H-positive risk:  660 668 105 1149 392 103 1050 411 181 68 153 60 
H-negative risk:  668 660 1050 1149 411 392 103 105 153 181 60 68 
New BC onsets:  99
BC status:  4901 99 
BC subtype:  4901 72 27 

clinical_engagement 
diagnosis 
demography 
83 new agents 
311 
disease_progression 
H-positive risk:  657 666 104 1149 394 107 1051 413 178 67 155 59 
H-negative risk:  666 657 1051 1149 413 394 107 104 155 178 59 67 
New BC onsets:  100
BC status:  4900 100 
BC subtype:  4900 73 27 

clinical_engagement 
diagnosis 
demography 
70 new agents 
312 
disease_progression 
H-positive risk:  655 662 104 1144 398 108 1057 416 177 65 157 57 
H-negative risk:  662 655 1057 1144 416 398 108 104 157 177 57 65 
New BC onsets:  101
BC status:  4899 101 
BC subtype:  4899 74 27 

clinical_engagement 
diagnosis 
demography 
68 new agents 
313 
disease_progression 
H-positive risk:  656 657 107 1145 400 110 1054 417 176 68 155 55 
H-negative risk:  657 656 1054 1145 417 400 110 107 155 176 55 68 
New BC onsets:  102
BC status:  4898 102 
BC subtype:  4898 75 27 

clinical_engagement 
diagnosis 
demography 
68 new agents 
314 
disease_progression 
H-positive risk:  651 657 109 1150 407 109 1047 419 178 65 154 54 
H-negative risk:  657 651 1047 1150 419 407 109 109 154 178 54 65 
New BC onsets:  102
BC status:  4898 102 
BC subtype:  4898 75 27 

clinical_engagement 
diagnosis 
demography 
80 new agents 
315 
disease_progression 
H-positive risk:  646 662 111 1144 412 108 1045 422 175 64 154 57 
H-negative risk:  662 646 1045 1144 422 412 108 111 154 175 57 64 
New BC onsets:  103
BC status:  4897 103 
BC subtype:  4897 76 27 

clinical_engagement 
diagnosis 
demography 
83 new agents 
316 
disease_progression 
H-positive risk:  643 664 110 1153 409 109 1043 415 174 66 156 58 
H-negative risk:  664 643 1043 1153 415 409 109 110 156 174 58 66 
New BC onsets:  103
BC status:  4897 103 
BC subtype:  4897 75 28 

clinical_engagement 
diagnosis 
demography 
84 new agents 
317 
disease_progression 
H-positive risk:  642 673 110 1143 410 110 1040 412 178 67 156 59 
H-negative risk:  673 642 1040 1143 412 410 110 110 156 178 59 67 
New BC onsets:  106
BC status:  4894 106 
BC subtype:  4894 78 28 

clinical_engagement 
diagnosis 
demography 
82 new agents 
318 
disease_progression 
H-positive risk:  643 669 111 1154 410 111 1036 416 174 63 154 59 
H-negative risk:  669 643 1036 1154 416 410 111 111 154 174 59 63 
New BC onsets:  102
BC status:  4898 102 
BC subtype:  4898 75 27 

clinical_engagement 
diagnosis 
demography 
94 new agents 
319 
disease_progression 
H-positive risk:  654 670 112 1157 407 112 1024 419 170 62 156 57 
H-negative risk:  670 654 1024 1157 419 407 112 112 156 170 57 62 
New BC onsets:  100
BC status:  4900 100 
BC subtype:  4900 76 24 

clinical_engagement 
diagnosis 
demography 
86 new agents 
320 
disease_progression 
H-positive risk:  661 670 110 1159 404 109 1025 416 169 58 158 61 
H-negative risk:  670 661 1025 1159 416 404 109 110 158 169 61 58 
New BC onsets:  100
BC status:  4900 100 
BC subtype:  4900 76 24 

clinical_engagement 
diagnosis 
demography 
70 new agents 
321 
disease_progression 
H-positive risk:  671 666 110 1159 401 108 1022 417 170 55 159 62 
H-negative risk:  666 671 1022 1159 417 401 108 110 159 170 62 55 
New BC onsets:  97
BC status:  4903 97 
BC subtype:  4903 74 23 

clinical_engagement 
diagnosis 
demography 
78 new agents 
322 
disease_progression 
H-positive risk:  674 670 108 1153 402 106 1015 420 175 56 162 59 
H-negative risk:  670 674 1015 1153 420 402 106 108 162 175 59 56 
New BC onsets:  96
BC status:  4904 96 
BC subtype:  4904 73 23 

clinical_engagement 
diagnosis 
demography 
78 new agents 
323 
disease_progression 
H-positive risk:  674 667 106 1154 398 106 1020 420 174 59 164 58 
H-negative risk:  667 674 1020 1154 420 398 106 106 164 174 58 59 
New BC onsets:  96
BC status:  4904 96 
BC subtype:  4904 71 25 

clinical_engagement 
diagnosis 
demography 
80 new agents 
324 
disease_progression 
H-positive risk:  666 661 106 1158 397 109 1030 422 173 57 166 55 
H-negative risk:  661 666 1030 1158 422 397 109 106 166 173 55 57 
New BC onsets:  93
BC status:  4907 93 
BC subtype:  4907 69 24 

clinical_engagement 
diagnosis 
demography 
65 new agents 
325 
disease_progression 
H-positive risk:  662 665 105 1150 400 107 1036 428 175 56 164 52 
H-negative risk:  665 662 1036 1150 428 400 107 105 164 175 52 56 
New BC onsets:  91
BC status:  4909 91 
BC subtype:  4909 67 24 

clinical_engagement 
diagnosis 
demography 
89 new agents 
326 
disease_progression 
H-positive risk:  671 666 102 1138 401 104 1045 427 174 55 166 51 
H-negative risk:  666 671 1045 1138 427 401 104 102 166 174 51 55 
New BC onsets:  92
BC status:  4908 92 
BC subtype:  4908 67 25 

clinical_engagement 
diagnosis 
demography 
79 new agents 
327 
disease_progression 
H-positive risk:  670 661 102 1146 397 106 1042 433 170 58 165 50 
H-negative risk:  661 670 1042 1146 433 397 106 102 165 170 50 58 
New BC onsets:  94
BC status:  4906 94 
BC subtype:  4906 70 24 

clinical_engagement 
diagnosis 
demography 
77 new agents 
328 
disease_progression 
H-positive risk:  669 666 102 1141 389 106 1051 434 167 60 165 50 
H-negative risk:  666 669 1051 1141 434 389 106 102 165 167 50 60 
New BC onsets:  93
BC status:  4907 93 
BC subtype:  4907 69 24 

clinical_engagement 
diagnosis 
demography 
63 new agents 
329 
disease_progression 
H-positive risk:  671 662 102 1139 389 105 1054 433 167 61 164 53 
H-negative risk:  662 671 1054 1139 433 389 105 102 164 167 53 61 
New BC onsets:  93
BC status:  4907 93 
BC subtype:  4907 69 24 

clinical_engagement 
diagnosis 
demography 
75 new agents 
330 
disease_progression 
H-positive risk:  676 660 103 1130 387 105 1059 431 164 63 171 51 
H-negative risk:  660 676 1059 1130 431 387 105 103 171 164 51 63 
New BC onsets:  91
BC status:  4909 91 
BC subtype:  4909 67 24 

clinical_engagement 
diagnosis 
demography 
86 new agents 
331 
disease_progression 
H-positive risk:  675 656 101 1120 397 106 1073 423 164 62 170 53 
H-negative risk:  656 675 1073 1120 423 397 106 101 170 164 53 62 
New BC onsets:  89
BC status:  4911 89 
BC subtype:  4911 65 24 

clinical_engagement 
diagnosis 
demography 
68 new agents 
332 
disease_progression 
H-positive risk:  680 652 105 1116 403 105 1066 419 163 65 173 53 
H-negative risk:  652 680 1066 1116 419 403 105 105 173 163 53 65 
New BC onsets:  85
BC status:  4915 85 
BC subtype:  4915 64 21 

clinical_engagement 
diagnosis 
demography 
76 new agents 
333 
disease_progression 
H-positive risk:  673 649 105 1108 400 103 1075 424 166 68 174 55 
H-negative risk:  649 673 1075 1108 424 400 103 105 174 166 55 68 
New BC onsets:  86
BC status:  4914 86 
BC subtype:  4914 63 23 

clinical_engagement 
diagnosis 
demography 
70 new agents 
334 
disease_progression 
H-positive risk:  673 653 105 1108 404 104 1073 422 164 65 174 55 
H-negative risk:  653 673 1073 1108 422 404 104 105 174 164 55 65 
New BC onsets:  82
BC status:  4918 82 
BC subtype:  4918 59 23 

clinical_engagement 
diagnosis 
demography 
76 new agents 
335 
disease_progression 
H-positive risk:  675 659 101 1104 396 103 1073 428 162 66 177 56 
H-negative risk:  659 675 1073 1104 428 396 103 101 177 162 56 66 
New BC onsets:  78
BC status:  4922 78 
BC subtype:  4922 56 22 

clinical_engagement 
diagnosis 
demography 
62 new agents 
336 
disease_progression 
H-positive risk:  679 651 101 1103 402 98 1072 430 169 65 175 55 
H-negative risk:  651 679 1072 1103 430 402 98 101 175 169 55 65 
New BC onsets:  79
BC status:  4921 79 
BC subtype:  4921 56 23 

clinical_engagement 
diagnosis 
demography 
79 new agents 
337 
disease_progression 
H-positive risk:  677 660 101 1095 394 101 1081 426 167 66 175 57 
H-negative risk:  660 677 1081 1095 426 394 101 101 175 167 57 66 
New BC onsets:  81
BC status:  4919 81 
BC subtype:  4919 58 23 

clinical_engagement 
diagnosis 
demography 
77 new agents 
338 
disease_progression 
H-positive risk:  677 663 103 1086 399 102 1087 422 165 68 173 55 
H-negative risk:  663 677 1087 1086 422 399 102 103 173 165 55 68 
New BC onsets:  85
BC status:  4915 85 
BC subtype:  4915 61 24 

clinical_engagement 
diagnosis 
demography 
78 new agents 
339 
disease_progression 
H-positive risk:  680 661 101 1080 402 103 1086 426 165 70 173 53 
H-negative risk:  661 680 1086 1080 426 402 103 101 173 165 53 70 
New BC onsets:  83
BC status:  4917 83 
BC subtype:  4917 59 24 

clinical_engagement 
diagnosis 
demography 
76 new agents 
340 
disease_progression 
H-positive risk:  675 664 103 1082 405 102 1087 419 164 71 175 53 
H-negative risk:  664 675 1087 1082 419 405 102 103 175 164 53 71 
New BC onsets:  83
BC status:  4917 83 
BC subtype:  4917 59 24 

clinical_engagement 
diagnosis 
demography 
64 new agents 
341 
disease_progression 
H-positive risk:  673 666 105 1078 409 100 1081 426 166 70 174 52 
H-negative risk:  666 673 1081 1078 426 409 100 105 174 166 52 70 
New BC onsets:  84
BC status:  4916 84 
BC subtype:  4916 59 25 

clinical_engagement 
diagnosis 
demography 
84 new agents 
342 
disease_progression 
H-positive risk:  672 666 102 1077 403 103 1087 421 170 70 177 52 
H-negative risk:  666 672 1087 1077 421 403 103 102 177 170 52 70 
New BC onsets:  87
BC status:  4913 87 
BC subtype:  4913 60 27 

clinical_engagement 
diagnosis 
demography 
69 new agents 
343 
disease_progression 
H-positive risk:  662 656 104 1068 408 102 1106 423 172 69 174 56 
H-negative risk:  656 662 1106 1068 423 408 102 104 174 172 56 69 
New BC onsets:  88
BC status:  4912 88 
BC subtype:  4912 58 30 

clinical_engagement 
diagnosis 
demography 
73 new agents 
344 
disease_progression 
H-positive risk:  658 661 104 1061 407 104 1112 426 172 67 174 54 
H-negative risk:  661 658 1112 1061 426 407 104 104 174 172 54 67 
New BC onsets:  88
BC status:  4912 88 
BC subtype:  4912 59 29 

clinical_engagement 
diagnosis 
demography 
88 new agents 
345 
disease_progression 
H-positive risk:  655 664 101 1067 407 99 1114 422 176 64 178 53 
H-negative risk:  664 655 1114 1067 422 407 99 101 178 176 53 64 
New BC onsets:  89
BC status:  4911 89 
BC subtype:  4911 59 30 

clinical_engagement 
diagnosis 
demography 
88 new agents 
346 
disease_progression 
H-positive risk:  651 663 100 1084 401 98 1110 418 175 64 183 53 
H-negative risk:  663 651 1110 1084 418 401 98 100 183 175 53 64 
New BC onsets:  85
BC status:  4915 85 
BC subtype:  4915 58 27 

clinical_engagement 
diagnosis 
demography 
60 new agents 
347 
disease_progression 
H-positive risk:  651 668 99 1082 404 96 1107 421 177 61 183 51 
H-negative risk:  668 651 1107 1082 421 404 96 99 183 177 51 61 
New BC onsets:  86
BC status:  4914 86 
BC subtype:  4914 60 26 

clinical_engagement 
diagnosis 
demography 
94 new agents 
348 
disease_progression 
H-positive risk:  653 675 100 1086 402 98 1101 413 178 63 178 53 
H-negative risk:  675 653 1101 1086 413 402 98 100 178 178 53 63 
New BC onsets:  86
BC status:  4914 86 
BC subtype:  4914 59 27 

clinical_engagement 
diagnosis 
demography 
78 new agents 
349 
disease_progression 
H-positive risk:  654 671 98 1092 402 99 1103 408 179 62 179 53 
H-negative risk:  671 654 1103 1092 408 402 99 98 179 179 53 62 
New BC onsets:  88
BC status:  4912 88 
BC subtype:  4912 60 28 

clinical_engagement 
diagnosis 
demography 
62 new agents 
350 
disease_progression 
H-positive risk:  645 672 98 1100 397 99 1104 409 177 63 181 55 
H-negative risk:  672 645 1104 1100 409 397 99 98 181 177 55 63 
New BC onsets:  90
BC status:  4910 90 
BC subtype:  4910 60 30 

clinical_engagement 
diagnosis 
demography 
77 new agents 
351 
disease_progression 
H-positive risk:  642 671 98 1101 396 98 1109 413 172 67 180 53 
H-negative risk:  671 642 1109 1101 413 396 98 98 180 172 53 67 
New BC onsets:  93
BC status:  4907 93 
BC subtype:  4907 61 32 

clinical_engagement 
diagnosis 
demography 
87 new agents 
352 
disease_progression 
H-positive risk:  648 676 97 1095 394 99 1110 406 171 68 181 55 
H-negative risk:  676 648 1110 1095 406 394 99 97 181 171 55 68 
New BC onsets:  93
BC status:  4907 93 
BC subtype:  4907 62 31 

clinical_engagement 
diagnosis 
demography 
81 new agents 
353 
disease_progression 
H-positive risk:  648 671 97 1097 390 100 1116 408 173 68 178 54 
H-negative risk:  671 648 1116 1097 408 390 100 97 178 173 54 68 
New BC onsets:  97
BC status:  4903 97 
BC subtype:  4903 66 31 

clinical_engagement 
diagnosis 
demography 
71 new agents 
354 
disease_progression 
H-positive risk:  652 673 95 1102 391 96 1109 409 170 69 181 53 
H-negative risk:  673 652 1109 1102 409 391 96 95 181 170 53 69 
New BC onsets:  97
BC status:  4903 97 
BC subtype:  4903 66 31 

clinical_engagement 
diagnosis 
demography 
83 new agents 
355 
disease_progression 
H-positive risk:  658 672 95 1108 383 96 1101 415 174 67 180 51 
H-negative risk:  672 658 1101 1108 415 383 96 95 180 174 51 67 
New BC onsets:  96
BC status:  4904 96 
BC subtype:  4904 65 31 

clinical_engagement 
diagnosis 
demography 
86 new agents 
356 
disease_progression 
H-positive risk:  655 672 95 1109 386 95 1100 420 173 66 176 53 
H-negative risk:  672 655 1100 1109 420 386 95 95 176 173 53 66 
New BC onsets:  95
BC status:  4905 95 
BC subtype:  4905 67 28 

clinical_engagement 
diagnosis 
demography 
72 new agents 
357 
disease_progression 
H-positive risk:  661 672 90 1100 386 100 1099 430 168 66 175 53 
H-negative risk:  672 661 1099 1100 430 386 100 90 175 168 53 66 
New BC onsets:  95
BC status:  4905 95 
BC subtype:  4905 66 29 

clinical_engagement 
diagnosis 
demography 
92 new agents 
358 
disease_progression 
H-positive risk:  669 674 89 1093 377 100 1104 435 170 63 174 52 
H-negative risk:  674 669 1104 1093 435 377 100 89 174 170 52 63 
New BC onsets:  95
BC status:  4905 95 
BC subtype:  4905 67 28 

clinical_engagement 
diagnosis 
demography 
66 new agents 
359 
disease_progression 
H-positive risk:  671 674 88 1095 379 99 1099 442 172 60 173 48 
H-negative risk:  674 671 1099 1095 442 379 99 88 173 172 48 60 
New BC onsets:  95
BC status:  4905 95 
BC subtype:  4905 68 27 

clinical_engagement 
diagnosis 
demography 
74 new agents 
360 
disease_progression 
H-positive risk:  663 663 88 1103 382 98 1109 441 174 60 170 49 
H-negative risk:  663 663 1109 1103 441 382 98 88 170 174 49 60 
New BC onsets:  97
BC status:  4903 97 
BC subtype:  4903 70 27 

clinical_engagement 
diagnosis 
demography 
69 new agents 
Time difference of 18.99692 mins
This is task 14
date
